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Zusammenfassung 
 
Schlaganfälle gehören zu den häufigsten Todesursachen in der westlichen Welt und verur-
sachen in Deutschland jährlich Kosten in Höhe von etwa 6 Milliarden Euro. Etwa 80% aller 
Schlaganfälle sind ischämische Schlaganfälle und werden meist durch einen Verschluss 
einer hirnversorgenden Endarterie verursacht. Trotz intensiver Forschungsarbeit sind die 
molekularen pathophysiologischen Mechanismen des Schlaganfalls nur teilweise aufgeklärt 
und derzeit ist keine kausale Therapie vorhanden, die die Konsequenzen des ischämischen 
Insults behandelt.  
Die Bluthirnschranke (BHS), eine Struktur bestehend aus Endothelzellen, Astrozyten und 
Perizyten, trennt das Gehirn von der Peripherie, ermöglicht aber den Einstrom von essen-
tiellen Metaboliten in das Gehirn. Während eines Schlaganfalls werden die Verbindungen 
zwischen den Endothelzellen degradiert, was eine erhöhte Durchlässigkeit der BHS zur 
Folge hat und schließlich durch Wassereinstrom ein vasogenes Ödem induziert.  
Die durch den Gefäßverschluss bedingte lokale Unterversorgung initiiert eine Folge von 
Ereignissen, die als ischämische Kaskade bekannt ist. Innerhalb weniger Minuten führen 
durch Hypoxie und Anoxie ausgelöste Mechanismen zu Exzitotoxizität, ein Prozess bei dem 
neuronaler Zelltod durch Überstimulation von Glutamatrezeptoren auf Neuronen, wie zum 
Beispiel den ionotropen NMDA-Rezeptor, hervorgerufen wird. Diese Überstimulation be-
wirkt einen massiven Ca2+-Einstrom und löst weitere Signalkaskaden aus, wie beispiels-
weise eine Dysfunktion von Mitochondrien. An der Funktion des NMDA-Rezeptors ist u.a. 
die Rezeptor-Tyrosin-Kinase EphB2 beteiligt und steuert den Ca2+-Einstrom durch den 
NMDA-Rezeptor in das Neuron. Das EphB/Ephrin-B-System ist ein Rezeptor-/Liganden-
System bei dem sowohl Rezeptor als auch Ligand membranständig sind. Für eine Bindung 
zwischen Rezeptor und Ligand ist demzufolge direkter Zellkontakt erforderlich. So konnte 
bereits gezeigt werden, dass EphB2 auf Monozyten mit Ephrin-B-Liganden auf Endothel-
zellen interagiert und dadurch sowohl eine Transmigration der Monozyten durch die En-
dothelzellschicht ermöglicht als auch den proinflammatorischen Phänotyp von Endothelzel-
len beeinflusst. 
Aus diesen Gründen war das Ziel dieser Arbeit, den Einfluss von EphB2/Ephrin-B-Liganden 
während zerebraler Ischämie zu untersuchen. 
In Ephb2-defizienten Mäusen wurde durch Okklusion der mittleren zerebralen Hirnarterie 
(MCAo) zerebrale Ischämie erzeugt, die von einer Reperfusionsphase gefolgt war. Analy-
sen von histologischen Färbungen, neurologischen Funktionen und des Transkriptoms 
ergaben, dass die Schlaganfallauswirkungen nach 12-48 h Reperfusion in Ephb2-defizien-
ten Mäusen gegenüber Wildtyp (WT) Mäusen abgeschwächt waren. Wie multiple 
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Untersuchungen (u.a. CT-Scans, Immunfluoreszenzfärbungen, BHS-Permeabilität-Assays) 
zeigten, war eine Störung der vaskulären Funktion nicht die Ursache dieser Beobachtung.  
Weitere Untersuchungen auf Basis von MRT-Scans ergaben jedoch, dass sich in Ephb2-
defizienten Mäusen innerhalb der ersten 6 h nach Reperfusion ein zytotoxisch bedingtes 
Ödem geringer ausprägte und auf eine neuronale Ursache hinwies. 
Analysen von Hirnlysaten aus WT Mäusen zeigten in diesem Zusammenhang, dass EphB2 
nach 6 h Reperfusion in der ischämischen Hemisphäre aktiviert wird (gemessen anhand 
des Phosphorylierungsstatus). Als nächstes wurde der Einfluss von EphB2 auf die NMDA-
Rezeptor-Funktion getestet. Es stellte sich heraus, dass in Ephb2-defizienten Neuronen 
NMDA-Rezeptor-abhängiger Ca2+-Einstrom in Mitochondrien sowie NMDA-Rezeptor-ab-
hängige mitochondriale Membrandepolarisierung gegenüber WT Neuronen vermindert wa-
ren. Da mitochondriale Dysfunktionen ein entscheidendes Merkmal der Schlaganfallpatho-
genese ist und einen Mechanismus im Rahmen der Induktion von Exzitotoxizität darstellt, 
wurde eine Zelltodanalyse durchgeführt. Breitgefächerte Exzitotoxizität führte jedoch nicht 
zu unterschiedlichen Anteilen toter Zellen zwischen WT und Ephb2-defizienter Neuronen.  
Zusammenfassend zeigt diese Arbeit erstmals, dass EphB2 innerhalb von 6 h nach Schlag-
anfall aktiviert wird und entscheidend zur zytotoxischen Ödembildung beiträgt, wohingegen 
die BHS-Permeabilität nicht durch EphB2 verändert wird. Bei Abwesenheit von EphB2 sind 
die Auswirkungen eines Schlaganfalls wir Infarkt- und Ödemvolumen oder neurologische 
Defizite abgeschwächt. In Ephb2-defizienten Neuronen sind NMDA-Rezeptor-gesteuerte 
mitochondriale Antworten vermindert, was die Wichtigkeit von EphB2 in Bezug auf die 
NMDA-Rezeptor-Funktion betont. EphB2-gesteuerte Mechanismen tragen demnach zu 
Signalprozessen bei, die schließlich zum neuronalen Zelltod führen. 
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Abstract 
 
Stroke is the number two cause of death in the western world and responsible for about 6 
billion euros economic costs caused by illness in Germany annually. Approx. 80% of all 
strokes are ischemic strokes and often develop from a focal cerebral hypoperfusion caused 
by an occlusion of a major cerebral artery. Despite intensive research, the pathophysiolog-
ical and regenerative molecular mechanisms of stroke are only partially understood and no 
causative therapy dealing with the consequences of the ischemic insult is available. 
The blood-brain barrier (BBB) is a structure built up by endothelial cells, astrocytes and 
perizytes. It separates the brain from the periphery while still allowing essential metabolites 
to cross. During cerebral ischemia transendothelial connections are degraded and the BBB 
permeability increases. This eventually causes vasogenic edema formation. 
The vessel occlusion-induced local hypoperfusion unleashes a series of events called is-
chemic cascade. Within minutes, hypoxia- and anoxia-induced intracellular mechanisms 
lead to excitotoxicity, a process which describes neuronal cell death induction caused by 
overstimulation of ionotropic glutamate receptors, such as NMDA receptors. Overactivation 
of NMDA receptors leads to massive Ca2+ influx into neurons and triggers signaling cas-
cades, which among others cause mitochondrial dysfunction and eventually cell death. 
Among others, the receptor tyrosine kinase EphB2 interacts with the NMDA receptor and 
regulates NMDA receptor functions which lead to increased Ca2+ influx through the NMDA 
receptor in the neuron. 
The EphB/ephrin-B system is a receptor/ligand system, in which both, receptor and ligands 
are membrane-bound requiring direct cell-to-cell contact in order to induce signaling pro-
cesses. Additionally, it had been shown that interaction of monocytic EphB2 with endothelial 
ephrin-B ligands influences transendothelial migration and induces a pro-inflammatory phe-
notype in endothelial cells. Therefore, this study aims to unravel the involvement of 
EphB2/ephrin-B signaling during cerebral ischemia.  
Cerebral ischemia was induced in Ephb2-deficient mice by transient middle cerebral artery 
occlusion (MCAo) followed by different times of reperfusion. Histological, neurofunctional 
and transcriptome analyses demonstrated that progression of stroke after 12-48 h of reper-
fusion is attenuated in Ephb2-deficient mice as compared to wild-type (WT) mice. However, 
multiple analyses (CT scans, immunofluorescence staining techniques, BBB permeability 
assays) showed that this observation was not caused by an impact on vascular function. 
On the other hand, further evaluations based on magnetic resonance imaging revealed that 
cytotoxic edema formation during the first 6 h after reperfusion was diminished in Ephb2-
deficient mice as compared to WT mice pointing towards a neuronal cause.  
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In this context, analysis of brain lysates from WT animals revealed that activation (shown 
by phosphorylation) of EphB2 was increased after 6 h of reperfusion in the ischemic hemi-
sphere. Next, the influence of EphB2 on neuronal NMDA receptor function was investigated. 
It turned out that NMDA receptor-mediated Ca2+ transients and mitochondrial membrane 
depolarization was decreased in Ephb2-deficient neurons as compared to WT neurons. As 
mitochondrial dysfunction is a hallmark of stroke pathogenesis and a crucial step during 
induction of excitotoxicity, cell death assays were performed. Widespread exposure to ex-
citotoxic stimuli did not reveal differences in the fraction of dead cells between WT and 
Ephb2-deficient mice though.  
Collectively, this is the first study to show that EphB2 is activated within 6 h after stroke and 
decisively contributes to cytotoxic edema formation while BBB permeability is not influenced 
by EphB2. In the absence of EphB2, progression of stroke is attenuated with respect to 
infarct and edema volume as well as neurological function. NMDA receptor-mediated mito-
chondrial responses are decreased in Ephb2-deficient neurons highlighting its importance 
for the function of the NMDA receptor. Hence, EphB2-dependent mechanisms contribute to 
signaling events that eventually worsen stroke progression.  
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1 Introduction 
 
1.1 Cells of the central nervous system 
The cells of the vertebrate central nervous system (CNS) can be classified into neurons and 
glial cells (glia from Greek γλία, "glue"). Nerve cells process and transmit information 
through the CNS supported by the glial cells, which outnumber the neurons in the brain. 
Glial cells can be further subdivided into different classes, such as astrocytes, oligodendro-
cytes, and microglia (Purves and Williams, 2001). Astrocytes, the most abundant glial cells, 
have several functions, such as modulating synaptic transmission, providing nutrients to the 
nervous tissue and in maintaining extracellular homeostasis. Additionally, they contribute to 
the formation of the blood-brain barrier (BBB) (Sofroniew and Vinters, 2010). Oligodendro-
cytes mainly contribute to the enhancement of signal conduction speed by enwrapping ax-
ons with a myelin sheath (Nave, 2010). Microglia are the resident macrophages of the CNS 
and in addition to their function as immune defense of the CNS, they play a crucial role in 
maintenance of functional and structural integrity (Aloisi, 2001; Ginhoux et al., 2013). Neu-
rons are responsible for receiving, processing and transmission of information through the 
nervous system (Purves and Williams, 2001).  
 
1.2 Neuronal synapses 
The principle steps during neuronal development are proliferation, migration, and differen-
tiation (Jin, 2016; Shimada and Langman, 1970). Among others, the formation of synaptic 
structures in neurons is crucial in order to establish a functional network of signal transmis-
sion. Synapses are contact sites between a neuron and another cell. Between two neurons, 
contacts usually form between the axon of the signal-passing neuron and a dendrite of the 
receptive neuron. Though formation of synapses pre-dominantly occurs during embryogen-
esis and early postnatal life, also in the adult brain new connections are constantly formed 
and reorganized, for instance during learning and memory formation. The complex process 
of synaptogenesis comprises structural and cell morphological changes and is mediated by 
proteins that affect time and place of synapse formation, and further influence stability and 
specificity of the contact site. Known molecules and proteins include soluble factors as well 
as membrane-bound molecules (Gerrow, 2006; Waites et al., 2005).  
Synapses can be subdivided into two major classes: chemical and electrical synapses. At 
the axon-terminal (presynaptic side) of chemical synapses, highly specialized proteins build 
up a machinery complex optimized to release neurotransmitters. Those are stored in vesi-
cles located within the presynapse and are released into the synaptic cleft by membrane 
fusion of the vesicles with the active zone of the presynapse (Purves and Williams, 2001). 
The fusion process is mediated by proteins of the so-called SNARE complex (Jahn and 
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Scheller, 2006). Neurotransmitters interact with receptors located on the receptive cell at 
the postsynapse. Usually, the release of neurotransmitters is triggered by activation of volt-
age-gated calcium channels due to changes in electrical activity. Changes in electrical ac-
tivity rise at the axon hill, a specialized site in a neuron, by generation of an action potential 
(AP), which propagates along the axon and finally depolarizes the axon terminal. Once the 
released neurotransmitters bind to postsynaptic receptors, the chemical signal originating 
from an electrical signal, is converted back into an electrical one thereby propagating signal 
transmission through the whole network. Chemical synapses are further subdivided accord-
ing to the neurotransmitter they release, e.g. glutamatergic (release of glutamate, interaction 
with NMDA and AMPA receptors, mainly propagating excitatory signals) or GABAergic (re-
lease of GABA, interaction with GABA receptors, mainly propagating inhibitory signals) 
(Purves and Williams, 2001). 
In an electrical synapse, electric currents are transmitted through gap junctions. Gap junc-
tions are built up by specialized protein cluster, which form a pore, and enable direct ex-
change of electrical impulses as well as ions and small molecules between pre- and 
postsynaptic cell (Purves and Williams, 2001).  
 
1.2.1 Synaptogenesis 
Formation of chemical synapses involves several signaling pathways which regulate the 
different steps from initiation to stabilization and finally function. First, axons are guided by 
secreted factors, such as semaphorins or netrins, to their respective target site (Gerrow, 
2006; Waites et al., 2005). Semaphorins act as inhibitory signal because their signaling 
induces remodeling of the actin cytoskeleton leading to growth cone collapse of the axon 
(Meyer et al., 2017). Axonal and dendritic maturation is driven by priming factors including 
fibroblast growth factor (FGF) or Wnts released by neurons or cholesterol and thrombos-
pondin released by glial cells (Waites et al., 2005). Wnts interact with the membranous re-
ceptor Frizzle and induce remodeling and spreading of growth cones (Lucas and Salinas, 
1997). Initial contacts between an axon and a dendrite are mediated by cell adhesion mol-
ecules (CAMs) belonging to the family of cadherins and protocadherins. Once adhered, 
neuroligins and neurexins, as well as EphB receptors and ephrin-B ligands, promote syn-
aptic differentiation by the recruitment of proteins belonging to the presynaptic active zone, 
the postsynaptic density as well as glutamate receptors. Synaptic maturation primarily com-
prises morphological changes of the premature synaptic sites. Spine morphogenesis is in-
duced by interaction of cell adhesion proteins regulating small GTPases such as Ras and 
Rho (Scheiffele, 2003; Waites et al., 2005). After recruitment of glutamate receptors, cal-
cium transients can signal into the postsynaptic site and drive gene expression further 
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modulating growth of dendrites, synapse maturation and finally neuronal plasticity (Greer 
and Greenberg, 2008).  
 
1.3 Cerebral circulation 
Though the human brain makes up only approx. 2-3% of total body weight, it requires 15% 
of the cardiac output and up to 20% of the energy produced in the whole body (Jain et al., 
2010). Due to the lack of energy storages, neurons are more vulnerable to changes in oxy-
gen and glucose levels than any other cell which requires a tight regulation of cerebral blood 
flow (CBF) and extravasation of blood components (Cipolla, 2009).  
Three kinds of regulatory mechanisms supposedly contribute to cerebral autoregulation 
which enables adequate and relatively constant CBF despite changes in the peripheral 
blood pressure. Firstly, cerebral pressure autoregulation involves endothelial mechanoprop-
erties that respond to shear stress and transmural pressure, and myogenic activity of cere-
bral vascular smooth muscle cells. Secondly, cerebral metabolism influences CBF, such as 
release of adenosine, a by-product of neuronal activity that is known to act as a vasodilator. 
Thirdly, neurogenic regulation is mediated by the functional unit of endothelial cell, astro-
cytes and perivascular nerves (Paulson et al., 1990).  
The blood-brain barrier (BBB) is a selective membrane that separates the brain and the 
circulating blood. Thereby it shields the brain from fluctuations in the composition of the 
blood or toxins, while still allowing the passage of essential metabolites. The BBB is formed 
by endothelial cells which are surrounded by a basement membrane, astrocytic endfeet, 
and pericytes. Together with neurons and the extracellular matrix, they form the so-called 
neurovascular unit (NVU). Within this unit, each component fulfills individual tasks thereby 
contributing to the regulation of microvascular permeability, cerebral hemodynamics, nutri-
ent uptake and toxin removal.  
The endothelial cells in the BBB are distinct from other endothelial cells as they lack fenes-
tration, have minimal pinocytic activity, low rate of transcytosis and are interconnected by 
tight junctions, which are a barrier to paracellular diffusion. Tight junctions are formed by 
transmembranous proteins like claudins and occludins and cytoplasmic adaptor molecules 
such as Zona occludens 1 (ZO-1). Adherens junctions, which usually are strictly separated 
from tight junctions, are intermingled with tight junctions in the endothelial cells of the BBB 
and formed by VE-cadherin and CD31 (PECAM1). The junctional units interact with the 
actin cytoskeleton enabling rapid morphological changes (Sandoval and Witt, 2008).  
The abluminal site od endothelial cells is surrounded by pericytes, which are also involved 
in the development of the BBB. Further, pericytes are important regulators of microvascular 
permeability and stability of microvessels as they secrete inhibitory signals which reduce 
the rate of endothelial transcytosis. The perivascular endfeet of astrocytic glial cells provide 
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a cellular link to the neurons and express, among others, channels involved in ion and vol-
ume regulation. Further, astrocytes secrete a range of molecules with angiogenic charac-
teristics such as angiopoietin 1 or vascular endothelial growth factor (VEGF) thereby influ-
encing and modulating BBB permeability. Structural proteins of the extracellular matrix pro-
vide support and anchorage for EC, pericytes, and astrocytes which adhere among others 
through integrins to the ECM (Sandoval and Witt, 2008).  
 
1.4 Cerebral ischemia 
In the year 2015, more than 6 million people died from stroke worldwide and therefore, 
stroke is considered as the second most common cause of death. Approximately 80% of all 
strokes are ischemic stroke. Ischemic strokes mostly result from an occlusion of a major 
cerebral end artery initiating a series of events called ischemic cascade which often devel-
ops from a focal cerebral hypoperfusion. Hypoperfusion leads to the first step of the is-
chemic cascade: depletion of adenosine triphosphate (ATP), the main energy source. Sub-
sequently, energy-dependent ion pumps fail thereby causing depolarization of glial cells and 
neurons. Voltage-dependent Ca2+ channels are activated, excitatory neurotransmitters like 
glutamate are released and accumulate in the extracellular space as the re-uptake by as-
trocytes is also impaired. Excessive glutamate leads to overstimulation of N-methyl-D-as-
partate (NMDA) receptors, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 
receptors and kainate receptors which causes massive Ca2+ influx into neurons inducing 
mitochondrial dysfunction. Subsequently, more glutamate is released unleashing the is-
chemic cascade. Together with Ca2+, water follows passively, thereby causing cytotoxic 
edema. Ca2+-induced signaling processes lead to formation of reactive oxygen species 
(ROS) and activation of degradative enzymes (Brouns and De Deyn, 2009).  
Both, extrasynaptically and synaptically located NMDA receptors are activated by glutamate 
inducing Ca2+ influx into the postsynaptic cell, which is important for synaptic plasticity and 
learning but can also induce excitotoxic cell death. Ca2+ influx drives gene expression in-
volved in long-term potentiation and depression as well as cell survival. Among others, the 
transcription factor cAMP-response element-binding protein (CREB) is activated during cer-
ebral ischemia and induces a neuroprotective response through CRE-mediated gene induc-
tion (Mabuchi et al., 2001). Surviving neurons exposed to ischemia show sustained CREB 
activation and expression of neurotrophic factors such as brain-derived neurotrophic factor 
(BDNF). However, activation of extrasynaptic NMDA receptors does not induce expression 
of BDNF but suppresses CREB activity (Hardingham and Bading, 2010). Further, Ca2+ en-
tering through especially extrasynaptic NMDA receptors accumulates largely in mitochon-
dria which finally results in breakdown of the mitochondrial membrane potential, ATP syn-
thesis and formation of ROS (Dugan et al., 1995; Hardingham et al., 2002; Stanika et al., 
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2009a). In addition to the localization of NMDA receptor, the composition of subunits of 
NMDA receptors influences responses to ischemia-induced glutamate excess. NMDA re-
ceptors are built up of an essential NR1 subunit encoded by the gene GRIN1, regulatory 
NR2 (NR2A-D) subunits encoded by GRIN2x genes, and partially an NR3 subunit (GRIN3). 
Most functional NMDA receptors in the CNS consist of two NR1 subunits, and at least one 
NR2 subunit, which are in the majority of cases the subunits NR2A and/or NR2B. Together 
they form a channel pore which only opens if the two agonists glycine and glutamate bind 
to their binding-sites at the NR1 and NR2 subunit, respectively (Kalia et al., 2008b). NR2B-
containing NMDA receptors are predominantly located at extrasynaptic sites and NR2B in-
teracts upon ischemia among others with death-associated protein kinase 1 (DAPK1). The 
NR2B-DAPK1 interaction mediates induction of neuronal cell death (Shu et al., 2014; Tu et 
al., 2010). In general, NMDA receptor function depends on phosphorylation at different ty-
rosine residues within the different subunits. For example, the Src-family tyrosine kinase 
Fyn phosphorylates Y1472 in NR2B (Nakazawa et al., 2001) which contributes to neuronal 
cell death upon ischemia (Knox and Jiang, 2015).  
The dysbalance in ion-homeostasis induces additional signaling cascades, which do not 
lead to vasodilation but to further hypoperfusion as well as changes in the electrical activity. 
This together triggers propagation of ischemia, a process called spreading depolarization 
(Dirnagl et al., 1999). Mechanisms inducing cell death comprise caspase-dependent apop-
tosis as well as caspase-independent processes, such as neuronal necrosis or autophagy-
like cell death (Fujikawa, 2015; Sattler and Tymianski, 2001).  
Neuronal cell death triggers a secondary, inflammatory response in which both parenchymal 
cells of the brain (microglia, astrocytes) as well as invading leukocytes (monocytes/macro-
phages, lymphocytes, dendritic cells) are involved. Interaction of resident microglia, astro-
cytes and cerebrovascular endothelial cells with dying neurons and further, the ischemic 
environment induce up-regulation of pro-inflammatory cytokine and chemokine production. 
Resident microglia in the brain are rapidly activated and release various kinds of cytotoxic 
mediators, like tumor necrosis factor alpha (TNFa) or interleukin 1β (IL-1β), but also cyto-
protective mediators like BDNF or insulin-like growth factor I (IGF-I) (Guruswamy and ElAli, 
2017). Additionally, ischemic conditions promote formation of ROS which are also released 
into the brain parenchyma. Astrocytes can be activated by ROS and subsequently release 
further cytokines and chemokines. Additionally, expression of inducible nitric oxide synthase 
(iNOS) is increased. Furthermore, astrocytic glutamate uptake is impaired due to energetic 
failure triggering excitotoxicity as mentioned above. Peripheral leukocytes adhere to the 
endothelium within several hours upon stroke, eventually transmigrate through the BBB and 
contribute to the inflammatory environment in the brain parenchyma. Cytokines induce up-
regulation of adhesion molecules in endothelial cells like intercellular adhesion molecule 1 
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(ICAM-1) or E-selectin (Brouns and De Deyn, 2009). Together with chemokines like mono-
cyte chemoattractant protein 1 (MCP1), peripheral immune cells are recruited and transmi-
grate through the BBB and finally, migrate into the infarct area (Dirnagl et al., 1999; 
Gelderblom et al., 2009).  
 
 
Figure 1: Graph depicting time course of processes in the ischemic cascade and their impact on the 
final damage. Adapted and modified from Brouns and Deyn (Brouns and De Deyn, 2009).  
 
Importantly, tissue damage upon cerebral ischemia can be divided into two zones: the in-
farct core and the penumbra. The infarct core is defined by a reduction in cerebral blood 
flow below 20% which almost immediately triggers the ischemic cascade and necrotic cell 
death (Dirnagl et al., 1999). The collateral arteries in the surrounding tissue of the core 
region (periinfarct) are still perfused supplying the tissue with oxygen and glucose. However, 
as blood flow is reduced, this area is defined as the penumbra, a tissue undergoing mild 
ischemia. Cells within the penumbra are still viable for several hours and can be rescued. 
Though infarct sizes can be reduced by quick restoration of blood flow, reperfusion con-
versely contributes to brain injury itself, a process called ischemic reperfusion (I/R) injury, 
as it increases the risk of cerebral hemorrhage (Nour et al., 2013). Figure 1 illustrates the 
different signaling cascades contributing to tissue damage during and after cerebral ische-
mia (Figure 1).  
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1.5 Eph/ephrin system 
1.5.1 Classification and structure 
Erythropoietin-producing human hepatocellular receptors, short Eph, represent the largest 
family of receptor tyrosine kinases (RTK). Eph receptors interact with ephrin ligands, which 
are also membrane-bound, requiring direct cell-to-cell contact in order to induce signaling 
processes. Eph receptors can be further subdivided into two subclasses based on their 
binding affinity and similarities of the extracellular sequences (Nomenclature and Ligands, 
1997). There are 10 EphA receptors which preferably bind to the GPI-anchored ephrin-A 
molecules and 6 EphB receptors which preferably bind to transmembranous ephrin-B mol-
ecules. While interaction between EphA and ephrin-A often triggers signaling processes in 
the receptor cell only, interaction of EphB receptors and ephrin-B ligands triggers bidirec-
tional signaling in both cells. The signaling process in the receptor-cell is called forward 
signaling while in the ligand-bearing cell reverse signaling is induced. The extracellular do-
main of an Eph receptor includes a ligand-binding globular domain, a cysteine-rich region, 
and two fibronectin type III repeats. The cytoplasmic part of an Eph receptor consists of 4 
different regions, a short juxtamembrane domain with several conserved tyrosine residues, 
the tyrosine kinase domain, a sterile α motif (SAM) protein-protein interaction domain and 
a PDZ-binding motif at the C-terminus. Ephrin-A ligands lack a cytoplasmic domain but 
some of them have been shown to induce downstream-signaling processes by activation of 
further kinases, possibly by acting as coreceptors or clustering microdomains (Holen et al., 
2008). In contrast, ephrin-B ligands have a cytoplasmic tail with conserved tyrosine phos-
phorylation sites and a C-terminal PDZ-binding motif. Receptor and ligand are often ex-
pressed on the same cell enabling cis-signaling within the same cell, while interaction be-
tween two different cells is called trans-activation. However, cis binding does not trigger 
signaling processes itself but seems to inhibit the responsiveness of Eph receptors 
(Pitulescu and Adams, 2010). Figure 2 represents the structure of Eph receptors and ephrin 
ligands (Figure 2). 
Eph receptor-ephrin ligand interaction is disrupted by endocytosis of the Eph/ephrin com-
plex into either the receptor- or the ligand-bearing cell. Noteworthy, surrounding membrane 
compartments including other proteins such as VEGF receptors are also internalized 
(Pitulescu and Adams, 2010; Sawamiphak et al., 2010; Wang et al., 2010). Additionally, the 
interaction can be eliminated through proteolytic cleavage by gamma-secretases or ADAM 
family metalloproteases (Klein, 2012; Pitulescu and Adams, 2010). 
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Figure 2: Scheme depicting structural features of Eph receptors and ephrin ligands.  
 
1.5.2 Signaling events 
As many different cell types express a plethora of proteins of the Eph/ephrin family, the 
Eph/ephrin receptor-ligand system controls various biological processes during embryogen-
esis and adult life by influencing cellular behavior. Eph/ephrin signaling plays an important 
role during embryogenesis such as vasculogenesis and neurogenesis by induction of at-
traction and repulsion, attachment and de-attachment, as many signaling processes trig-
gered by this receptor-ligand-system regulate the cytoskeleton.  
Eph receptors are activated by phosphorylation upon interaction with ephrin ligands through 
autophosphorylation at several tyrosine residues and further by Src-family kinases (Lisabeth 
et al., 2013). The phosphorylated kinase domain mostly interacts with SH2 domain-contain-
ing proteins such as Rho and Ras or the focal adhesion kinase FAK (Brückner and Klein, 
1998). 
Similar to Eph receptor activation, ephrin-B ligands are phosphorylated at their cytoplasmic 
tyrosine residues upon activation. Eph receptor binding induces recruitment and activation 
of Src family kinases to ephrin clusters which mediate ephrin-B phosphorylation (Palmer et 
al., 2002). The phosphorylated tyrosine residues can then be recognized by SH2-domain 
proteins, for example, growth-factor-receptor-bound protein 4 (Grb4). Interaction of Grb4 
with ephrin-B induces disassembly of stress fibers and increase in FAK activity (Cowan and 
Henkemeyer, 2001). In addition, ephrin-B ligands can also be (co-)activated by growth 
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factor receptors such as Tie2 or cell membrane proteins such as claudins (Daar, 2012) and 
ephrin-B reverse signaling is further involved in Src-, ROCK-, JNK- and PI3K-dependent 
signaling processes (Bochenek et al., 2010; Palmer et al., 2002; San Miguel et al., 2011; 
Xu et al., 2003). 
 
1.5.3 EphB/ephrin-B in the vascular system 
The embryonic development of the (cardio-)vascular system includes initiation of formation 
of the vascular network (vasculogenesis) and remodeling and expansion processes of such 
(angiogenesis). The EphB/ephrin-B system plays a crucial role in this process since expres-
sion of EphB4 on endothelial cells identifies those as veins while ephrin-B2-positive struc-
tures are arteries. Optimal endothelial ephrin-B2 levels are required for proper formation of 
the capillary network and angiogenesis because ephrin-B2-deficient, as well as ephrin-B2 
overexpression in EC, leads to embryonic death. EphB4 Null mice exhibit a similar pheno-
type like ephrin-B2 deficient mice and die in utero as well (Gerety et al., 1999). Ephrin-B2 
is also expressed on mural cells. In smooth muscle cells, it is involved in their migration to 
lymphatic capillaries as well as formation of the microvascular architecture and depletion of 
ephrin-B2 in mural cells results in perinatal lethality (Foo et al., 2006). Other members of 
the EphB/ephrin-B family are expressed on arteries as well as veins such as ephrin-B1 and 
EphB3 indicating that EphB/ephrin-B interaction does not solely define arterial and venous 
boundaries. In addition, interaction of EphB and ephrin-B proteins in the surrounding mes-
enchymal cells with endothelial cells mediate proper development of vessels since 
EphB2/EphB3 double mutant mice exhibit vascular defects (Adams et al., 1999). Further, 
ephrin-B1 is expressed on arteries and veins, EphB3 mainly by veins and ephrin-B2 and 
EphB2 are expressed on mesenchymal cells (Adams et al., 1999).  
The EphB/ephrin-B system was well-studied during embryogenesis but is also involved in 
processes during adulthood. In tumors and wounds, sites of neovascularization, expression 
of ephrin-B2 in endothelial cells is upregulated (Bochenek et al., 2010) and participates in 
angiogenic signaling (Nakayama et al., 2013). In a model of ischemia/reperfusion injury, 
EphB4 and ephrin-B2 were upregulated in endothelial cells in hypoxic skin tissue indicating 
an involvement of the EphB/ephrin-B system after hypoxic injury (Vihanto et al., 2005). Fur-
ther, VEGF receptor endocytosis depends on ephrin-B2, while ephrin-B2 expression is up-
regulated by VEGF (Salvucci and Tosato, 2012). However, the EphB/ephrin-B system is 
better known for its regulatory function during migration of inflammatory cells through the 
endothelium. Cell culture studies revealed that endothelial ephrin-B1 and -B2 mediates ad-
hesion of monocytes and affects their transmigration through an endothelial  monolayer 
(Korff et al., 2008; Liu et al., 2014; Pfaff et al., 2008). In line with this, monocytes showed 
upregulation and phosphorylation of EphB2 upon adhesion to endothelial cells and 
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interaction with ephrin-B2 and release of chemokines (Braun et al., 2011). Further, ephrin-
B2 interacts with endothelial junctional proteins and increases endothelial cell permeability 
upon activation by EphB2 possibly through diminishing junctional integrity (Liu et al., 2014).  
 
 
Figure 3: Scheme depicting interaction of monocytic EphB2 and endothelial ephrin-B1/2 during in-
flammation. Reverse signaling processes in endothelial cells induce disassembly of endothelial junc-
tions thereby increasing endothelial permeability. Subsequently, monocytes are guided through the 
endothelial monolayer by further interaction of EphB2/ephrin-B2. Scheme according to Liu et al. (Liu 
et al., 2014). 
 
Figure 3 represents the proposed mechanism how monocytic EphB2 interacts with endo-
thelial ephrin-B leading to increasing endothelial permeability and transmigration of mono-
cytes through the endothelial monolayer (Figure 3). 
 
1.5.4 EphB/ephrin-B in the nervous system 
The EphB/ephrin-B system has been intensively studied for its role in the nervous system. 
It contributes to the patterning of brain structures, axon guidance, topographic mapping and 
further to synapse formation and synaptic plasticity. EphB receptors EphB2 and EphB3 and 
ephrin-B ligands ephrin-B1, -B2 and -B3 support segmentation and boundary formation of 
anatomic structures during development by complementary expression patterns in the hind-
brain. The receptor-ligand interaction induces repulsion thereby stabilizing boundaries and 
restricting intermingling and movement of cells (Becker et al., 1994; Cooke et al., 2005). 
EphB receptors are crucial during axonal guidance and mutations in ephrin-B3 and several 
EphB receptors result in defects in major brain commissures connecting the two hemi-
spheres. For example, the cytoplasmic domain of EphB2 is essential for proper migration 
of axons of the posterior tract of the anterior commissure, a lateral axon tract linking the two 
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temporal lobes (Henkemeyer et al., 1996). EphB3 essentially participates in the formation 
of the corpus callosum, another commissural axon tract connecting the two hemispheres 
(Orioli et al., 1996). Further, EphB/ephrin-B interaction mediates the topographic mapping 
in the dorsal retina. Forward and reverse signaling processes contribute to guidance of ret-
inal ganglion cell axons (Hindges et al., 2002; Thakar et al., 2011).   
As mentioned previously, the EphB/ephrin-B system contributes to synaptogenesis and 
spine morphogenesis. Neuronal dendrites form small protrusions referred to as spines, pro-
vide the postsynaptic structure of most excitatory synapses. Interaction of EphB2 with 
ephrin-B triggers presynaptic differentiation (Kayser et al., 2006). Direct interaction of the 
extracellular domain with the NR1 subunit of NMDA receptors induces recruitment of NMDA 
receptors to Eph receptor clusters (Dalva et al., 2000; Nolt et al., 2011), while localization 
of AMPA-type receptors depends on the cytoplasmic domain of EphB2 (Kayser et al., 2006). 
Stimulation of neurons with ephrin-B1 enhances colocalization of EphB2 and NMDA recep-
tors and increases the number of NR1 at presynaptic sites (Dalva et al., 2000). Synapse 
morphology is not altered in Ephb2-deficient mutants, however, NR1 synaptic levels are 
reduced and in EphB1/B2/B3 triple mutants, hippocampal spine density is decreased 
(Henkemeyer et al., 2003). Defects in EphB1/B2/B3 triple mutants can partially be rescued 
by postnatal induction of EphB2 expression in single neurons in brain slices (Kayser et al., 
2006). Spine morphogenesis is modulated by EphB receptors through regulation of key 
regulators of actin dynamics as Rho family GTPases or induction of phosphorylation of 
syndecan-2, another protein known for regulation of spine morphogenesis (Ethell et al., 
2001; Irie et al., 2005). EphB2 is also involved in NMDA receptor function. Ephrin-B2 acti-
vation of EphB receptors enhances NMDA receptor-dependent Ca2+ influx by activation of 
Src family members which subsequently phosphorylates the NMDA receptor subunit NR2B 
at tyrosine residue 1472. Interestingly, this enhancement is not observed in cells transfected 
with an EphB2 mutant that cannot bind Src family members. Further, NMDA receptor-me-
diated Ca2+-influx and gene expression upon glutamate stimulation are enhanced after pre-
treatment with ephrin-B2 (Takasu, 2002). NMDA receptor subunit localization and amount 
of NMDA receptors at synapses are regulated by EphB2 (Nolt et al., 2011). Functional de-
fects in NDMARs in Ephb2-deficient mutants result in a reduction in long-term potentiation 
and synaptic NMDA receptor-mediated currents (Grunwald et al., 2001). Proteins of the 
EphB/ephrin-B family also mediate interactions between neuronal and non-neuronal cells 
or between different cell types within the nervous system. During optic nerve injury, macro-
phages expressing EphB3 seem to interact with damaged axons of retinal ganglion cells 
thereby modulating axonal re-extension and sprouting (Liu et al., 2006). Upon injury, astro-
cytes play a crucial role in mediating inflammation and tissue repair. Astrocytic ephrin-B1 is 
upregulated after traumatic brain injury and seems to trigger synapse remodeling through 
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STAT3 signaling (Nikolakopoulou et al., 2016). Noteworthy, inhibition of ephrin-B2/EphB4 
signaling between astrocytes and endothelial as well as perivascular cells worsen post-
stroke neurovascular repair mechanisms indicating a crucial function in neurovascular ho-
meostasis upon cerebral ischemia (Ghori et al., 2017).  
Figure 4 summarizes the role of EphB2 and the ligands ephrin-B1/2 during maturation of 
synapses and synaptic function (Figure 4). 
 
 
Figure 4: Role of EphB2 and ephrin-B1/2 during synapse formation and synapse function. Left side 
shows signaling towards remodeling of spines by activating small GTPases, while recruitment of 
certain adapter molecules leads to activation of RhoA and inhibition of synapse maturation. Right 
side shows interaction of EphB2 with the NMDA receptor upon binding to ephrin-B and subsequent 
recruitment of Src family kinases which induces phosphorylation (℗) of the NMDA receptor. This is 
followed by Ca2+ influx and activation of gene transcription. Black dots: glutamate. Adapted and mod-
ified from Dalva 2012 and Sheffler-Collins 2013 (Dalva, 2010; Sheffler-Collins and Dalva, 2012). 
 
1.5.5 The EphB/ephrin-B system in other systems 
Apart from the mentioned involvement of the EphB/ephrin-B system in the nervous and 
vascular system, other biological processes are influenced by EphB receptors and ephrin-
B ligands. EphB6 is involved in T-cell responses during experimental autoimmune enceph-
alitis (Luo et al., 2004). During arteriosclerosis, a chronic proinflammatory disease during 
which arterial walls undergo abnormal thickening and hardening, arteriosclerotic plaque for-
mation is possibly influenced by the interaction of endothelial ephrin-B2 with monocytic 
EphB2. Differentiation of monocytes into macrophages as well as their adhesion to endo-
thelial cells and subsequent upregulation of cytokine gene expression are modified by the 
abundance of EphB2 and ephrin-B2 (Braun et al., 2011).   
RhoA
synapse
maturation
GEF
GTPase
spine morpho-
genesis
EphB2
ephrin-B1/2
Ca2+
transcription
EphB2
ephrin-B1/2
presynapse
postsynapse
NMDAR
Src
Introduction 
 
 
17 
 
EphB/ephrin-B binding has been linked to bone formation as the interaction between oste-
oclasts and osteoblasts through ephrin-B2 and EphB receptors promote osteoclast differ-
entiation while inhibiting osteoblast differentiation and EphB2/B3 or ephrin-B1 mutant mice 
develop skeletal malformations (Pasquale, 2008).  
The EphB/ephrin-B system has also intensively been studied in the context of cancer. 
Dysregulation of EphB/ephrin-B expression levels has been shown for several cancer enti-
ties and can lead to inhibition but also to promotion of cancer progression. Interestingly, in 
tumor samples derived from human breast cancer patients, particularly high expression lev-
els of cytoplasmic EphB2 were correlated with poor survival (Husa et al., 2016). Further, 
studies showed that EphB2 expression reduces tumor growth by induction of apoptosis in 
breast cancer cells. Additionally, EphB2 is linked to increased expression of pro-invasive 
genes like MMP2 or 9 (Chukkapalli et al., 2014).  
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1.6 Rationale and aims of this study 
The EphB/ephrin-B system is involved in diverse processes, such as the formation of neu-
ronal synapses, the development of vascular structures, the formation of interendothelial 
contacts, transendothelial migration, activation of monocytes and function of NMDA recep-
tors – processes which play an important role in the pathogenesis of stroke. However, its 
role has not been investigated so far in this context of cerebral ischemia. Based on the 
original results and the functional features of the EphB/Ephrin system, it is assumed that 
EphB2 and EphB2-mediated signaling processes may i) influence progression of stroke as 
it possibly ii) modulates the blood-brain barrier (BBB), iii) affects neuronal cell death and iv) 
modifies the inflammatory responses which may all influence lesion formation upon stroke.  
 
Consequently, the main aims of this project were: 
i) Evaluation of infarct and edema sizes as well as motoric impairments upon 
stroke in Ephb2-deficient mice in comparison to WT and further, activation of 
EphB2 during cerebral ischemia in vivo. 
ii) Investigation of changes in blood-brain barrier permeability dynamics over time 
and impact on endothelial junctions in the absence and presence of EphB2 in 
vivo. 
iii) Analysis of neuronal cell death and impact of EphB2 on NMDA receptor function 
in the context of excitotoxicity in vitro. 
 
While the project described in this thesis focusses on parts i) - iii), another project part fo-
cusing on the involvement and response of the immune system is covered by Laura-Inés 
Böhler (AG Marti). In accordance with animal welfare, data sets requiring sacrificing of ani-
mals were used in this project as well as in the project of Laura-Inés Böhler.  
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2 Materials 
 
Table 1: Equipment used in this study. 
Equipment Supplier Model Application 
Camera Hamamatsu ORCA flash 4.0 Imaging, Tissue 
Gnostics system 
capillary electropho-
resis device 
ProteinSimple, Bio-
techne 
Wes protein separation 
    
Cryostat microtome Leica Biosystems Leica CM1520 cryo-sectioning 
Digital Imaging Sys-
tem Image Quant 
GE Healthcare LAS 4000 mini Proteome Profiler 
Fluorescence mi-
croscope 
Zeiss Axiovert 200M Imaging, Tissue 
Gnostics system 
Fluorescence mi-
croscope 
Olympus IX83 Imaging, CellSense 
system 
Hypoxia working 
station 
Ruskinn Invivo2 Plus cell culture, OGD 
Laboratory mill Retsch Mixermill MM301 Tissue lysis 
laser-Doppler flow-
metry probe 
PeriMed PROBE 407-1 small 
straight probe 
regional blood flow 
measurement 
multichannel laser 
Doppler system 
PeriMed PeriFlux 4001 Mas-
ter 
regional blood flow 
measurement 
NanoDrop Thermo-Fisher Sci-
entific 
ND-1000 RNA concentration 
Plate reader Bio-Tek BioTek Synergy 
HAT 
Evans Blue, Brad-
ford 
pump, peristaltic  TSE systems Is-
matec 
Reglo Analog MS-
416 
particle perfusion 
pump, rate ASID Bonz PP50 transcardial perfu-
sion 
rotating wheel UGO Basile S.R.L. Mouse RotaRod 
NG 
behavioral studies 
 
Table 2: Materials used in animal experiments.  
Materials 
animals  
Supplier 
Catalogue 
number 
Application 
0.9% NaCl B.Braun Melsungen 3570130 i.v. injection 
Bepanthen eye 
cream 
Bayer Vital GmbH  animal surgeries 
Adult Mouse Brain 
Slicer Matrix 
Zivic instruments 
 
BSMAS001-1 brain preparation 
cannula, 21G BD Microlance 304432 transcardial perfu-
sion 
Clip Applicator For-
ceps Style 
F.S.T. Fine Science 
Tools 
18057-14 animal surgeries, 
brain dissection 
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Dumont #5 Fine 
Forceps  
F.S.T. Fine Science 
Tools 
11254-20 animal surgeries, 
brain dissection 
Dumont #7 Fine 
Forceps  
F.S.T. Fine Science 
Tools 
11274-20 animal surgeries, 
brain dissection 
Evans Blue Sigma Aldrich E2129 i.v. injection 
Graefe Forceps - 
Curved/Serrated 
F.S.T. Fine Science 
Tools 
11051-10 animal surgeries 
Mathieu Needle 
Holder - 14 cm 
F.S.T. Fine Science 
Tools 
12010-14 animal surgeries 
Micro Serrefine F.S.T. Fine Science 
Tools 
18055-04 animal surgeries 
Ölfarbe Norma® 
Professional Haut-
ton 
Schmincke 11220015 particle perfusion 
PBS Sigma Aldrich D8537 transcardial perfu-
sion 
PERMA-HANDTM 
silk suture 3-0 
ETHICON 6PA3544 (no longer 
available)  
animal surgeries 
RESORBA® silk 
suture 5-0 
RESORBA Medical 
GmbH 
G2105 animal surgeries 
silicone rubber-
coated monofila-
ment for MCAo, 7-0 
Doccol Corporation 70191012PK5Re animal surgeries 
Tissue-Tek® 
O.C.T.TM com-
pound 
Sakura Finetek 4583 tissue embedding 
Vannas Spring 
Scissors 
F.S.T. Fine Science 
Tools 
15000-00 animal surgeries 
 
Table 3: Chemicals and reagents used in this study (without cell culture). 
Chemicals and 
Reagents 
Supplier 
Catalogue 
number 
Application 
10X Sample Buffer Protein Simple 042-195 c.e. 
12-230 kDa Wes Sep-
aration Module 
Protein Simple SM-W004 c.e. 
5X GoTaq® G2 Flexi 
buffer 
Promega M891A genotyping 
Anti-Rabbit Detection 
Module 
Protein Simple DM-001 c.e. 
BSA Sigma Aldrich A2153 blocking buffer 
Capillary Cartridges  Protein Simple 009-050 c.e. 
casein Sigma Aldrich C5890 blocking buffer 
cresyl violet Merck 1052350025 cresyl violet stain 
DAPI Molecular Probes D1306 nuclear staining 
EnVision+ System- 
HRP 
DAKO K4002 EphB/ephrin-B 
staining 
Eukitt Kindler  embedding 
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Fluoro-Jade C Chemicon AG325 FJC staining 
goat serum Dianova 005-000-121 blocking buffer 
GoTaq® G2 Flexi 
DNA polymerase 
Promega M7805 genotyping 
Halt™ Protease and 
Phosphatase Inhibitor 
Cocktail 
Thermo Science 
Fisher 
78442 protein lysis buffer 
KMnO4 Merck 1.055082.0250 FJC staining 
LowCross buffer Candor 100125 IF staining 
Luminol Protein Simple 043-311 c.e. 
MgCl2, 25 mM Promega A351H genotyping 
Mowiol 4-88 Calbiochem 475904 embedding 
NonidetTM P 40 sub-
stitute (NP-40) 
Sigma Aldrich 4385 staining 
PCR Nucleotide Mix 
dNTP 
Promega C114G genotyping 
Peroxide Protein Simple 043-379 c.e. 
Pre-filled microplate Protein Simple 043-165 c.e. 
primer Eurofins Genomics  genotyping 
protease inhibitor 
cocktail 
Sigma Aldrich P9599 protein lysis buffer 
Protein Assay Dye 
Reagent 
Bio-Rad 5000006 Bradford assay 
Proteinase K Thermo Fisher AM2548 genotyping 
Proteome Profiler 
pRTK 
R&D systems 
 
ARY014 protein lysates 
RNAse- free DNase Promega M6101 genotyping 
RNAse-free H2O   genotyping 
RNAsin, 40 U/µL Promega N2615 genotyping 
RQ1 10X DNase 
buffer 
Promega M6101 genotyping 
saponin Sigma Aldrich 47036 permeabilization 
Standard Pack, Wes Protein Simple PS-ST01 c.e. 
Streptavidin-HRP Protein Simple 042-414 c.e. 
TRI Reagent Sigma Aldrich T9424 RNA isolation 
Tris Roth 4855.2 buffers 
TSA Plus Cy5 System PerkinElmer NEL745001KT EphB/ephrin-B 
staining 
Wash Buffer, Wes Protein Simple 042-202 c.e. 
Wes Antibody Diluent 
II 
Protein Simple 042-203 c.e. 
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Table 4: Primary antibodies used for staining and capillary electrophoresis (Wes). 
Antibody 
Clonality, 
host 
Supplier 
Catalogue 
number 
Dilution 
Appli-
cation 
beta-tubulin poly, rabbit Abcam ab6046 1:500 c.e. 
CD31 mono, rat BD Pharmingen 557355 1:100 IF 
desmin poly, rabbit Dianova DLN-13732 1:400 IF 
EphB2 poly, goat R&D systems AF467 1:2000 
1:10 
IF 
c.e. 
EphB4 poly, goat R&D systems AF446 1:1000 IF 
ephrin-B1 poly, goat R&D systems AF473 1:4000 IF 
ephrin-B2 poly, goat R&D systems AF496 1:500 IF 
GFAP poly, rabbit DAKO Z0334 1:1000 IF 
MAP2 poly, rabbit Chemicon ab5622 1:100 IF 
NeuN mono, mouse Novus Bio-techne NBP1-92693 1:500 IF 
ZO-1 poly, rabbit Invitrogen 61-7300 1:100 IF 
 
Table 5: Secondary antibodies used for staining and capillary electrophoresis (Wes). 
Antibody Supplier 
Catalogue 
number 
Dilution Application 
AF647-donkey-anti-mouse  Dianova 706-606-147 1:100 IF 
Cy3-donkey-anti-rabbit Dianova 711-166-152 1:200 IF 
Cy3-goat-anti-rabbit  JacksonImmu-
noResearch 
111-165-003 1:100 IF 
Cy5-donkey-anti-rat JacksonImmu-
noResearch 
712-606-150 1:100 IF 
FITC-donkey-anti-rat JacksonImmu-
noResearch 
712-096-150 1:100 IF 
Goat Anti-Rabbit Second-
ary HRP Conjugate 
R&D systems 042-206 ready-to-
use 
c.e. 
Goat IgG HRP-conjugated 
Antibody 
R&D systems HAF109 1:50 c.e. 
 
Table 6: Materials and substances used for neuronal cell culture. 
Cell culture product Supplier Catalogue number 
24-well plate Cellstar 662130 
B27 supplement Invitrogen 17504-044 
Bicuculline* ENZO Life Sciences ALX-550-515 
CaCl2x2H2O Merck 1.02382.1000 
Cytosine β-D-arabinofuranoside (AraC) Sigma C1768 
FCCP* Sigma-Aldrich C2920 
gabazine* Biotrend BN 0507 
Glucose Merck K33069537 
Glutamax Gibco 35050-038 
glycine Fisher Scientific UK G/0800160 
HEPES Roth 9105.2 
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Insulin-transferrin-sodium selenite me-
dia supplement  
Sigma Aldrich I1884 
K2SO4 powder Riedel-de Haën 31270 
Kynurenic acid Sigma Aldrich K3375-1G 
Laminin Sigma Aldrich L2020-1MG 
L-cystein Sigma C7352-25G 
MEM, no glutamine Gibco/Thermo Fisher 21090055 
MgCl2 x6 H2O powder Merck 5833 
Na2SO4 powder Sigma Aldrich 31481-1KG-R 
NaCl powder Sigma 31434-1KG-R 
NaHCO3 powder Riedel-de Haën 31437 
NaOH powder Sigma Aldrich 30620-1KG-R 
NBQX* HelloBio HB0443 
Neurobasal medium Gibco 21103 
nifedipine* Biotrend A10643 
NMDA* Biotrend BN0385 
OptiMEM Invitrogen 31985-054 
Papain from papaya latex Sigma Aldrich P3125-100MG 
PBS  Sigma Aldrich D8537 
PBS with Ca2+ and Mg2+ Sigma Aldrich D8662 
Penicillin-Streptomycin (10,000 U/mL) Gibco 15140122 
Phenol red Sigma Aldrich P0290-100ML 
Poly-D-lysine Sigma Aldrich P1149 
Rat serum Bio West S2150 
Rat serum  Abcam ab7488 
Sodium pyruvate solution 100 mM Sigma Aldrich S8636-100ML 
Sterile syringe filter 0.2 um Fisher Millipore SLGP033RS 
Trypsin inhibitor Sigma Aldrich T9253 
TTX* Biotrend BN0518 
verapamil* Tocris 0654 
*used by Dr Anna Hertle (Bading lab) 
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2.1 Solution, buffers, media 
If necessary, pH values of buffers were adjusted with 10 N or 1 N HCl or NaOH using a pH 
meter. 
 
Lysis buffer for genotyping 
50 mM KCl 
1.5 mM MgCl2 
10 mM Tris, pH 8.3 
0.45% NP-40 
0.45% Tween-20 
Freshly added: Proteinase K (20 µg/µL), eg. 1 µL to 150 µL lysis buffer 
 
Solution for amplification of DNA for genotyping (volumes in µL) 
 
Solute Concentration Volume in µL 
primer EphB2-F1 100 nM 0.3 
primer EphB2-N1B 100 nM 0.3 
primer Neo3 100 nM 0.3 
dNTP 10 mM 0.5 
MgCl2 25 mM 1.5 
5X GoTaq® G2 Flexi buffer 5X 5.0 
genomic DNA from lysis 2.0 
GoTaq® G2 Flexi DNA polymerase 5 U/µL 2.0 
dH2O  14.9 
 
Agarose gel for electrophoresis of DNA 
1-3% agarose  
90 mM Tris 
90 mM boric acid 
2.5 mM EDTA 
0.001% ethidium bromide 
 
PBS, pH 7.6 
137 mM NaCl 
2.7 mM KCl 
10 mM Na2HPO4 
1.5 mM KH2PO4 
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PBS-T 
0.05% Tween-20 in PBS 
 
TBS, pH 7.6 
50 mM Tris 
150 mM NaCl 
 
TBS-T 
0.05% Tween-20 in TBS 
 
Blocking buffer 
50 mM Tris, pH 7.6 
0.25% casein 
0.1% BSA 
15 mM NaN3 
 
Pigment solution 
16% Künstlerfarbe Schmincke Norma Professionals Hautton 
4% PFA 
In PBS 
 
Ringer’s solution 
154 mM NaCL 
5.6 mM KCl 
2.4 mM CaCl2 
6 mM NaHCO3 
5.6 mM dextrose 
freshly added: 0.1 mM nitroprusside, 0.1 mM adenosine 
 
PFA in PBS+supplements 
20 µM CaCl2 
40 mM sucrose 
4% PFA 
solved in 1XPBS 
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Zinc-fixative 
100 mM Tris, pH 7.4 
3.2 mM Ca(CH3COO)2  
22.8 mM ZnC4H6O4 
36.7 mM ZnCl2 
 
Mowiol 
2.4 g Mowiol 4-88 were added to 6 g glycerin and mixed with 6 mL dH2O for 3 h. Then, 
12 mL 200 mM Tris, pH 8.5 were added and the mixture was stirred at 53°C until fully solved. 
Mowiol was clarified by centrifugation at 5000xg for 20 min. Aliquots were made and stored 
at -20°C.  
 
Lysis buffer Proteome Profiler 
Lysis buffer 17 from Array Kit ARY014 
Addition of protease inhibitor cocktail according to manufacturer’s instruction 
 
2.2 Cell culture 
Poly-D-lysine 
Solved to a final concentration of 1 mg/mL in sterile H2O, divided into aliquots and stored at 
-20°C 
 
Stock solutions, sterilely filtered  
1 M NaOH 
0.2 M NaOH 
1 M HEPES 
1 M NaCl 
1 M KCl 
1 M NaHCO3 
2 M MgCl2 
1 M Na2SO4 
0.25 M K2SO4 
0.1 M CaCl2 
2.5 M glucose solution 
10 mM glycine 
100 mM mannitol 
Rat serums purchased from Abcam 
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Ky/Mg solution 
10.5 mM kynurenic acid, 100 mM MgCl2, 50 mM HEPES, 0.5% phenol red, adjusted to 
slightly acid pH with 1 M NaOH 
79.28 mg kynurenic acid 
5 mL H2O 
0.2 mL phenol red solution 
2.5x 0.2 µL 1 M NaOH 
incubated at 37°C for 30 min, mixed in between 
after kynurenic acid is in solution 
0.2 mL 1 M HEPES  
mixed 
2 mL 2 M MgCl2 
ad 40 mL H2O 
divided into aliquots, stored at -20°C 
 
Dissociation medium 
82 mM Na2SO4  
30 mM K2SO4  
6 mM MgCl2  
0.25 mM CaCl2  
1 M HEPES   
20 mM glucose 
0.2% Phenol red sol  
 
Dissection medium 
90% Dissociation medium 
10% Ky/Mg solution 
addition of 0.2 M NaOH until medium turns slightly purple indicating physiological pH 
value of approx. 7.5 (eg. 55 µL in 40 mL Dissociation medium) 
 
Enzyme solution 
To a solution consisting of 90% Dissociation medium and 10% Ky/Mg solution, L-cystein 
was added to a final concentration of 3.7 mM. Solutions was adjusted with 0.2 M NaOH 
and papain is added to a final concentration of 10 U/mL.  
45 mL DM 
5 mL Ky/Mg solution 
22.5 mg L-cystein 
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300-800 µL 0.2 M NaOH, until phenol red slightly turns purple indicating physiological pH 
value of approx. 7.5 
Mixed  
500 units of papain 
filtered sterilely once papain is in solution (takes 10-15 min) 
divided into aliquots, stored at -20°C 
 
Inhibitor solution 
To a solution consisting of 90% Dissociation medium and 10% Ky/Mg solution, 1% trypsin 
inhibitor was added. Solutions was adjusted with 0.2 M NaOH. 
90 mL DM 
10 mL Ky/Mg solution 
1 g trypsin inhibitor 
500-1000 µL 0.2 M NaOH, until phenol red slightly turns purple indicating physiological pH 
value of approx. 7.5 
filtered sterilely once inhibitor is in solution 
divided into aliquots, stored at -20°C 
 
Growth medium  
1X B27 supplement 
0.5 mM Glutamax 
100 U/mL Pen/Strep 
1% rat serum  
solved in Neurobasal A medium 
 
OptiMEM/glucose 
20 mM glucose in OptiMEM medium 
 
Salt glucose glycine solution (SGG) (also used as control medium during OGD ex-
periments) 
114 mM NaCl  
5.29 mM KCl  
1 mM MgCl2   
26.1 mM NaHCO3    
2 mM CaCl2   
10 mM HEPES    
30 mM glucose  
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1 mM glycine   
0.5 mM Sodium pyruvate solution    
0.2% Phenol red solution  
sterilely filtered, stored at 4°C 
 
OGD medium 
Medium had the same composition as SGG (see above) with the exception that glucose 
was substituted by equimolar mannitol. 
 
Insulin-transferrin-sodium selenite media supplement ITS 
One vial containing ≥21 mg recombinant human insulin; ≥19 mg human transferrin (sub-
stantially iron free), and 25 μg sodium selenite was solved in 50 mL acidified sterile water. 
1 vial added to 10 mL 10 mM HCl 
ad 50 mL sterile H2O 
divided into aliquots, stored at -20°C 
 
Transfection medium TM 
88% SGG 
10% MEM 
1.5% ITS 
0.5% Pen/Strep (100 U/mL) 
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3 Methods 
 
3.1 Animals 
All animal experiments were approved by the local animal welfare committee (Regier-
ungspräsidium Karlsruhe, Germany, approval number: 35-9185.81/G-112/13), conformed 
to the Guide for the Care and Use of Laboratory Animals published by the US National 
Institutes of Health and were performed in accordance with the recently published Animal 
Research: Reporting In vivo Experiments (ARRIVE) guidelines (http://www.nc3rs.org/AR-
RIVE). All mice used in the animal experiments were randomized. The surgeon or investi-
gator was blinded to the respective mouse genotypes throughout the experiments and eval-
uation of the read-out parameters. 
Male and female mice were used at the age of 7-9 weeks. For MRI scans, CT scans, RNA 
isolation, proteome profiler, and Evans Blue injections, only male mice were used. 
 
3.1.1 Maintenance and phenotype of Ephb2-deficient mice 
All mice were maintained at the animal facility of the University of Heidelberg under specific 
pathogen-free conditions, a controlled 12:12 h light-dark cycle, constant room temperature 
(22±2°C) and humidity (40-60%) with food and water ad libitum. Ephb2-/- (C57BL/6 back-
ground) mice were kindly provided by Prof. Dr. Rüdiger Klein (Max Planck Institute of Neu-
robiology, Munich, Germany). The protein null allele had been created by replacing 1.4 kb 
of the sequence, which includes the exon that encodes amino acids 29-50, by a neomycin 
resistance cassette thereby also inducing a frame shift downstream of the mutation (Hen-
kemeyer 1996). EphB2-defcient mice show an abnormal morphology of the anterior com-
missure pars posterior, a major forebrain commissure that connects the two temporal lobes 
of the cortex. In addition, Ephb2-/- mutants show a hyperactive behavior (Henkemeyer 
1996). Ephb2+/+ mice were either C57BL/6 wild type mice purchased from Jackson Lab or 
obtained from backcrossing of those wild type mice with Ephb2-/- mice. Ephb2+/- mice were 
derived from intercrossing of Ephb2+/+ and Ephb2-/- mice.  
 
3.1.2 Genotyping 
Tissue was lysed in 200-300 µL lysis buffer and incubated overnight at 55°C. Lysates were 
incubated for 5 min at 95°C and centrifuged at 100xg for 5 min. Supernatant contained 
genomic DNA. DNA lysate was mixed with nucleotide mix, MgCl2, and Taq polymerase. 
Primer (Table 7) were added and the target gene was amplified based on the following 
program: 94°C, 5 min; 35x (94°C, 15 s; 61°C, 40 s; 72°C, 90 s); 72°C, 10 min.  
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Then, the amplificon was applied to agarose gel electrophoresis. DNA was visualized by 
staining with ethidium bromide. Samples of Ephb2+/+ animals showed an amplificon with a 
size of approximately 450 bp, Ephb2-/- tissue one of 300 bp.   
 
Table 7: Primer sequences used for genotyping of animals used in this study 
Primer name Sequence  
EphB2 (F1), start exon 2, forward 5´-AAA CCC TGA TGG ACT CTA CGA CAG C-3´           
EphB2 (N1B), intron 2, reverse 5´-GTC AGT TTC ATA GCC TGA AGA ACG-3´ 
Neo transgene (Neo3), reverse 5’-GGG TAC ATC TCA GTG GTA GAA TG-3´ 
 
3.1.3 Middle cerebral artery occlusion 
Middle cerebral artery occlusion (MCAo) was done as described before (Barteczek et al., 
2017). In brief, mice were anesthetized for induction and maintenance by inhalation of a 
mixture containing 2.5-3.0% and 1.5% isoflurane, respectively, 70% N2O and remainder O2 
using a vaporizer. Body temperature was maintained at 37°C with a feedback-controlled 
heating pad. A midline neck incision was made and the left common carotid artery as well 
as its bifurcation internal carotid artery (ICA) were isolated and dissected from surrounding 
tissue. Then, a 7-0 silicon rubber-coated monofilament (Doccol Corporation) was induced 
into the left CCA and pushed through the ICA towards the middle cerebral artery. The inci-
sion was closed, and the intraluminal suture was left for 60 minutes. Animals were anesthe-
tized, and the filament was withdrawn to allow reperfusion. For sham surgery, the filament 
was inserted and withdrawn immediately. During MCAo and 30 min after start of reperfu-
sion, mice were kept under observation under a heating lamp at 30°C. Then, mice were 
placed in a heating cabinet at 30°C. If reperfusion time was longer than 24 h, mice were 
placed in a normal cabinet the next day. Mice received softened food pellets and easily 
accessible drinking bottles.   
 
3.1.4 Laser Doppler flowmetry 
Laser Doppler flowmetry was don as described before (Kunze et al., 2015; Li et al., 2016; 
Reischl et al., 2014). To measure regional cerebral blood flow (rCBF) reduction, a laser-
Doppler probe (Perimed Instruments) was positioned 1.5 mm posterior and 3 mm lateral to 
Bregma on the left side of the exposed skull. RCBF was measured right before and imme-
diately after induction of MCAo.  
 
3.1.5 Magnetic resonance imaging 
Magnetic resonance imaging (MRI) was performed at the division of Neuroradiology at the 
University Hospital Heidelberg (Prof. Dr. Martin Bendszus) by Dr. Angelika Hoffmann and 
Manuel Fischer. Animals were anesthetized for induction and maintenance by inhalation of 
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2% and 1-11.5% isofluorane, respectively, in air. Animals were fixed in a prone position in 
an animal holder equipped with a tooth bar and headlock to reduce head motion. Body 
temperature was maintained at 37°C using a feedback-controlled water bath and an in-
house developed program in LabView (National Instruments Corporation) was used to ex-
ternally monitor respiration. Animals were scanned on a small animal scanner at 9.4 Tesla 
magnetic field strength (BioSpec 94/20 USR, Bruker) using a volume coil for RF transmis-
sion and a 4-channel-phased-array surface receiver coil.  
MRI included different imaging set-ups as described before (Kunze et al., 2015): T2-
weighted imaging ((TEeff/TR = 66 ms/2650 ms, RARE factor = 8, slice thickness 0.5 mm, 13 
slices matrix 256 × 256, in plane resolution 78 μm × 78 μm), diffusion-weighted imaging 
TEeff/TR = 20 ms/3400 ms, slice thickness = 0.7 mm, 30 diffusion sensitized directions with 
a b-value of 1500 s/mm2, field-of-view 12 × 15 mm, matrix 96 × 128, resolution = 125 μm × 
117 μm), diffusion-weighted imaging TEeff/TR = 20 ms/3400 ms, slice thickness = 0.7 mm, 
30 diffusion sensitized directions with a b-value of 1500 s/mm2, field-of-view 12 × 15 mm, 
matrix 96 × 128, resolution = 125 μm × 117 μm), and quantitative T2 measurements (TE 
increments of 8 ms from 8 ms to 136 ms, TR = 3100 ms, slice thickness = 0.5 mm, matrix 
= 172 × 172, resolution = 116 μm × 116 μm). 
The real signal component from the Multislice Multiple Spin Echo data were fitted after 
phase correction and SNR optimized multiple coils signal combination on a voxel-by-voxel 
basis with the monoexponential function M0*e -(TE/T2) using a nonlinear least-squares fit pro-
cedure (MATLAB Release 2012b, The MathWorks, Inc.). 
Diffusion-weighted images by FSL's (FMRIB [The Oxford Centre for Functional Magnetic 
Resonance Imaging of the Brain] Software Library) FDT toolbox 
(http://www.fmrib.ox.ac.uk/fsl/fdt/index.html) were utilized to obtain apparent diffusion coef-
ficient (ADC) values. Images were analyzed with the software Amira (Visage Imaging, Inc.). 
Manual region growing was performed by using a threshold-based pre-segmentation to de-
termine the ischemic lesion on ADC and T2 maps in basal ganglia (including striatum) and 
cortex.  
 
3.1.6 CT scan 
Computer tomographic (CT) scans were performed at the Division of Medical Physics in 
Radiology, DKFZ, by Dr. Dorde Komljenovic.  
Right before µCT imaging, 100 µl ExiTron™ nano CT contrast agent (Miltenyi Biotec, 
Bergisch Gladbach, Germany) were injected via the tail vein. Mice were anesthetized by 
inhalation anesthesia (3.5% Sevoflurane in room air) during µCT imaging and scanned with 
an Inveon scanner (Siemens Medical Solutions, Erlangen, Germany) with following param-
eters: 500 µA, 60kV, exposure time 600 ms, binning 1, rotation steps 720 RS, total rotation 
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360°, magnification Med-high, pixel size 30 µm. Images were obtained using OsiriX DICOM 
viewer (Bernex, Switzerland) with the identical parameters for both mice. 
 
3.1.7 Evaluation of neurological impairments after MCAo 
Motoric skills were assessed by using the Rotarod test. Mice were trained to run on a rotat-
ing wheel on 3 days with 3 runs each for 300 s with a linear increase from 5-40 rpm. On the 
day of the MCAo and the day afterward, mice were set on the wheel and time was measured 
until they fell off. 
In addition, neurological function was determined using the modified Bederson neurological 
deficit score before MCAo and at the end of the reperfusion time. The following scoring 
system was used:  
Score  0  No observable deficit 
Score  1  Forelimb flexion 
Score  2  Decreased resistance to lateral push 
Score  3  Unidirectional circling 
Score  4  No movement 
 
3.1.8 Visualization and analysis of brain vessels 
Mice were sacrificed by CO2 asphyxiation. Immediately after the onset of death, thorax cav-
ity was opened, the right atrium was incised leading to venous outflow, while a perfusion 
cannula (25G) was inserted into the left ventricle. Mice were perfused with approximately 
20 mL pre-warmed (37°C) Ringer’s solution containing vessel dilators through a peristaltic 
pump until blood was completely washed out. Then, perfusion was continued with approxi-
mately 10 mL of a pre-warmed pigment solution. Mice were decapitated and skulls were 
fixed overnight in 4% PFA in PBS with supplements at 4°C. The next day, brains were 
removed from skulls, placed in fresh PFA solutions for additional 3 h and images were taken 
under a dissecting microscope. Vessels and bifurcation supplying the area of the middle 
cerebral artery were manually counted.  
 
3.1.9 Tissue processing 
For histochemical, immunofluorescence staining, brain lysates for proteome profiler, capil-
lary electrophoresis and RNA analysis, mice were transcardially perfused. Mice were anes-
thetized with a mixture 3.0% isoflurane, 70% N2O and remainder O2 using a vaporizer. 
Thorax cavity was opened and a perfusion cannula (21G) was inserted into the left ventricle. 
The right atrium was incised and mice were perfused with PBS (RT) at a rate of 2 mL/min 
with a total volume of 10 mL, except for tissue harvest for proteome profiler and analysis 
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with simple western; here, cold PBS and a total volume of 8 mL was used. Subsequently, 
brains were carefully removed from the skull and processed for further analysis. 
For histochemical and immunofluorescence staining brains were harvested after 12, 24 or 
48 h of reperfusion and were embedded into Tissue-Tek (Sakura Finetek) and stored at -
80°C until usage.  
For isolation of RNA (48 h of reperfusion) and analysis of extravasation of Evans Blue (12 
and 24 h of reperfusion), olfactory bulbs and cerebellum were removed, hemispheres were 
separated, quickly frozen in liquid nitrogen, and stored at -80°C until further usage.  
For proteome profiler and capillary electrophoresis analysis (6 h of reperfusion), brains were 
harvested with pre-cooled instruments on ice. Brains were then placed into a pre-cooled 
brain slicer. Brains were aligned to the sliding groove according to their lambdoid and sag-
ittal sutures. Two pre-cooled razor blades were set around relative to Bregma 0.00±0.5 mm 
and Bregma 2.50±0.5 mm with a total distance of 3 mm. This thick brain slice was separated 
into its hemispheres and quickly frozen in liquid nitrogen. Tissue was stored at -80°C until 
further usage.     
 
3.1.10 Evans Blue injection and quantification 
2 h prior to the end of the reperfusion time, mice were anesthetized and 100 µL of a pre-
warmed (37°C) solution containing 2% Evans Blue (Sigma-Aldrich) in 0.9% NaCl were in-
jected into the tail vein through a syringe, which was subsequently flushed with 50-100 µL 
of a 0.9% NaCl solution to ensure full injection of the Evans Blue solution. Mice were kept 
under a heating lamp at 30°C for 2 h. Then, mice were transcardially perfused and brains 
were harvested as described above. For detection of extravasated Evans Blue, 500 µL ice-
cold 50% trichloroacetic acid (TCA) was added per hemisphere. Tissue was lysed with a 
grinding ball at 30 Hz for 2 min (Mixer Mill MM301, Retsch). Lysates were incubated for 2 h 
at 4°C and centrifuged at 16,000xg for 15 min at 4°C. The supernatant was used for quan-
tification. A serial dilution of Evans Blue in 50% TCA was made (1:2 series, starting from 40 
µg/mL to 0.625 µg/mL). Technical triplicates were pipetted into a 96-well and absorption 
was measured at 620 nm with a plate reader (Synergy HT, BioTek). 
       
3.1.11 RNA isolation from brain tissue and purification 
RNA was isolated according to manufactures instruction. In brief, 500 µL cold TRI Reagent 
(Sigma-Aldrich) (4°C) was added per hemisphere. Tissue was lysed with a grinding ball at 
1 Hz for 1 min (Mixer Mill MM301, Retsch). Then, 1 mL TRI Reagent was added and the 
lysates were allowed to stand for 5 min at RT. 200 µL chloroform per 1 mL Tri Reagent was 
added, samples were shaken vigorously for 15 s, and allowed to stand for 2-15 min at RT. 
The resulting mixture was centrifuged at 12,000xg for 15 minutes at 4 °C. Centrifugation 
Methods 
 
 
35 
 
separated the mixture into 3 phases: a red organic phase (containing protein), an interphase 
(containing DNA), and a colorless upper aqueous phase (containing RNA). The aqueous 
phase was transferred to a new tube, 0.5 mL of 2-propanol per mL TRI Reagent used in 
sample preparation was added and mixed by inverting the tube 15-20 times. Samples were 
allowed to stand at RT for 5-10 min and centrifuged at 16,100xg for 10 min at 4°C allowing 
the RNA to precipitate as a pellet on the side and bottom of the tube. The supernatant was 
decanted, and the pellet was washed twice by addition of 1 mL 75% ethanol per 1 mL TRI 
Reagent, centrifugation at 16,100xg for 5 min at 4°C and decanting of the supernatant. 
Then, remaining ethanol was completely removed, the pellet was briefly dried and finally 
dissolved in 30 µL RNAse-free H2O. RNA concentration was measured by a NanoDrop (ND-
1000, peqlab). 30 µg of isolated RNA was filled up to a final volume of 39 µL with RNase-
free H2O and the following agents were added: 5 µL RQ1 10X DNAse buffer, 3 µL RNAsin 
(40 U/µL), and 3 µL RNAse-free DNAse (all Promega). After 30 min incubation at 37°C, 
100 µL TRI Reagent was added, and the sample was processed as above. The resulting 
RNA pellet was dissolved in 20 µL RNAse-free H2O and stored at -80°C until further usage.    
 
3.1.12 Gene expression profiling 
Microarray analysis was performed at the Centre for medical research (ZMF) at the medical 
faculty Mannheim by Dr. Carsten Sticht.  
High quality of RNA was confirmed by capillary electrophoresis on an Agilent 2100 bioana-
lyzer (Agilent). Arrays of mouse MoGene-2_0-st-type from Affymetrix were used to perform 
gene expression profiling. GeneChip® WT Plus Reagent Kit and the GeneChip® Hybridi-
zation, Wash and Stain Kit (both from Affymetrix, Santa Clara, USA) were applied according 
to manufacturer's instruction to prepare biotinylated antisense cRNA. After hybridization on 
the chip on a GeneChip Hybridization oven 640, it was dyed in the GeneChip Fluidics Sta-
tion 450 and finally scanned with a GeneChip Scanner 3000. All of the equipment used was 
from the Affymetrix-Company (Affymetrix, High Wycombe, UK). 
Arrays were annotated using a Custom CDF Version 20 with ENTREZ based gene defini-
tions (Dai et al 2005). Quantile normalization and RMA background correction were used to 
normalize the raw fluorescence intensity. A commercial software package SAS JMP10 Ge-
nomics, version 7, from SAS (SAS Institute, Cary, NC, USA) was used to identify differen-
tially expressed genes by calculating an ANOVA. The level of significance was set to a false 
positive rate of a=0.05 with FDR correction. Presence of a statistically significant bias in the 
distribution of defined lists (or sets) of genes within a ranked gene list was tested with Gene 
Set Enrichment Analysis (GSEA; Subramanian et al). Pathways belonging to various cellu-
lar processes such as cell cycle or apoptosis were obtained from a public external database 
(KEGG, http://www.genome.jp/kegg). 
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3.1.13 Cryo-sectioning  
Brains embedded in Tissue-Tek were adapted to the optimal cutting temperature at approx-
imately -15°C in a Cryo-stat (Leica CM1520, Leica Biosystems). Coronal sections were cut 
at 10 µm thickness and mounted directly on polysine-coated microscope slides. For analysis 
of infarct and edema sizes, 24 coronal sections at a distance of 0.4 mm were collected and 
submitted to Nissl staining (see below). For immunofluorescence and Fluoro-Jade C stain-
ing, sections from +0.62 to -0.62 mm relative to Bregma were collected. Sections were 
briefly dried on a heating plate (37°C) and stored at -20°C until further usage. Regions were 
identified using the atlas The Mouse Brain in Stereotaxic Coordinated by Paxinos and 
Franklin. 
 
3.1.14 Cresyl violet staining and measurement of infarct and edema sizes 
All steps were performed at RT if not stated otherwise. Cresyl violet staining and calculation 
of infarct and edema sizes were done as described before (Reischl et al., 2014). In brief, 
cryosections were air-dried for 20 min. Then, sections were placed into a descending etha-
nol series: 15 min 96% ethanol, 1 min 70% ethanol, 1 min 50% ethanol. Sections were 
placed twice into dH2O for 2 and 1 min, respectively. Subsequently, sections were placed 
into an acetic cresyl violet solution (0.5% cresyl violet in 1% glacial acetic acid) at 60°C for 
10 min. Afterwards, sections were rinsed several times with dH2O and air-dried. The dye in 
the cresyl violet solutions stains RNA bluish violet thereby labeling healthy tissue, while 
damaged tissue appears light (cresyl violet-deficient) as shown in Figure 5. Stained sections 
were scanned and the sizes of both hemispheres, as well as the cresyl violet-deficient area 
which corresponds the infarct area, were measured by utilizing ImageJ. To calculate the 
infarct area of each section the following equation was applied: inf = (cresyl-def + total con-
tra - total ipsi), with inf = infarct area in mm², cresyl-def= cresyl violet-deficient area in mm², 
total contra= total area of the contralateral hemisphere in mm², total ipsi = total area of the 
ipsilateral hemisphere in mm². The total infarct volume was calculated as the summation of 
the total infarct area of each section multiplied by the distance between each section, which 
was 0.4 mm: infarct volume in mm³ = ∑inf (mm²) *0.4 mm. This equation includes a correc-
tion for the increase in the volume of the ipsilateral hemisphere due to vasogenic edema-
induced swelling. In line with this, the edema volume was calculated according to the fol-
lowing equation: edema volume (mm³) = ∑ (total ipsi (mm²) - total contra (mm²)) *0.4 mm. 
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3.1.15 Fluoro-Jade C staining and counting of dead neurons 
This method was adapted from that originally described by Schmued et al. (Schmued and 
Hopkins, 2000) and the manufacture’s instruction (Chemicon).  
All steps were performed at RT if not stated otherwise. 10 µm cryo-sections were air-dried 
for 10 min and fixed with 4% PFA in PBS for 15 min at RT. Then, slices were briefly im-
mersed in dH2O and dried on a slide warmer at 50°C for at least 30 min. Slices were rehy-
drated and permeabilized by immersion in basic ethanol consisting of 1% NaOH in 80% 
ethanol for 5 min followed by 2 min in 70% ethanol and dH2O, respectively. Fluorescent 
background was blocked and contrast was optimized by immersing slices in 0.06% KMnO4 
for 5 min on a rocking table followed by rinsing slices in dH2O for 2 min. Finally, slices were 
incubated in 0.0001% Fluoro-Jade C in 0.01% acetic acid including 1 µg/mL DAPI for 20 min 
in the dark. Then, slices were rinsed 3 times for 1 min in dH2O and placed on a slide warmer 
at 50°C until completely dry. After immersing slides in xylene for 1 min, slices were mounted 
with Eukitt (Kindler) and stored at RT in the dark until usage.  
Fluorescence staining was recorded using a Zeiss Axiovert 200M microscope with a Hama-
matsu ORCA flash 4.0 camera by applying TissueFAXS scanning software. Nuclei were 
identified by DAPI-staining. Number of cells showing fluorescent signal for Fluoro-Jade C 
was automatically counted by using TissueGnostics software. The anatomic structure of 
Caudate putamen was defined as striatum. The region of the cerebral cortex except was 
defined as shown in Figure 5.  
 
Figure 5: Image of sagittal brain section Nissl-
stained with cresyl-violet. The right side is the con-
tralateral, normoxic hemisphere. The left side is the 
ipsilateral, ischemic hemisphere. Infarct area is 
bright while viable tissue is darker. Bold dotted line 
indicates border of infarct. Dotted Thin dotted line la-
bels the area referred as cortex, continuous line la-
bels striatum. 
 
3.1.16 Immunofluorescence staining of brain slices 
All steps were performed at RT if not stated differentially. Details regarding antibodies and 
dilutions can be found in the material section at p 22.  
For immunofluorescent staining, all coronal cryo-sections (10 µm in thickness) were fixed 
with zinc-based fixative (in mM: 100 Tris (pH 7.4), 3 Ca(C2H3O2)2, 25 Zn(C2H3O2)2 and 35 
ZnCl2) for 30 min. Then, slices were immersed in ddH2O for 5 min.  
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Staining for EphB and ephrin-B proteins and vessels: Activity of endogenous peroxidase 
was blocked by incubation with 0.3% H2O2 in methanol for 10 min. Slices were immersed 3 
times in ddH2O for 3 min each. Subsequently, slices were incubated for 30-60 min with 
blocking buffer (0.1% BSA, 0.25% casein in 50 mM Tris) followed by incubation with over-
night at 4°C with the primary antibody. Next day, slices were washed 3 times in TBS-T for 
5 min. Slices were incubated for 30 min with a peroxidase-conjugated EnVision (DAKO, 
Agilent) reagent followed by incubation with a Tyramide Signal Amplification (Perkin Elmer) 
reagent for 1 min. When stained with antibodies against EphB-receptors, slices were incu-
bated with blocking buffer again followed by incubation with an antibody against CD31 over-
night at 4°C. Next day, slices were washed as before and incubated with an appropriate 
secondary antibody for 1 h.  
Staining for tight junctions and vessels: Slices were immersed 3 times in PBS for 5 min. 
Then, slices were permeabilized with 0.5% saponin in PBS for 10 min followed by 5 min in 
PBS and incubation with blocking buffer (10% goat serum in PBS-T) for 30 min. Subse-
quently, slices were incubated overnight at 4°C with the primary antibodies targeting for the 
tight junctional protein ZO-1. The next day, slices were washed 3 times with PBS-T for 5 
min followed by incubation with appropriate secondary antibodies for 1 h.    
Staining for pericytes and vessels: Slices were incubated for 30 min with blocking buffer 
consisting of 0.1% BSA and 0.25% casein in 50 mM Tris followed by incubation with over-
night at 4°C with the primary antibodies targeting for the endothelial cell adhesion molecule 
CD31 and desmin, a protein found in muscle cells and pericytes. Next day, slices were 
washed 3 times in TBS-T for 5 min followed incubation with appropriate secondary antibod-
ies for 1 h.  
Nuclei were counterstained with DAPI (1 µg/mL in PBS, 3 min). All antibodies were diluted 
in LowCross-Buffer (Candor). Stained sections were then embedded in Mowiol mounting 
medium (Polysciences) and stored at 4°C until imaging within 3 days. Fluorescence staining 
was recorded using a Zeiss Axiovert 200M microscope with a Hamamatsu ORCA flash 4.0 
camera.   
 
3.1.17 Analysis of vessels and pericyte-coverage of vessels 
To quantify the density of brain vessels, areas with CD31-specific fluorescence intensity 
were assigned as vessels. Areas, which were associated with desmin-specific fluorescence 
intensity was defined as an area of a vessel covered by a pericyte. A macro for Image J 
was used to quantify number of vessels and pericyte-coverage automatically. The macro 
was designed by Dr. Holger Lorenz, Imaging Faculty, Centre of Molecular Biology (ZMBH), 
Heidelberg University.   
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3.1.18 Phospho-RTK Proteome Profiler 
Phosphorylation levels of receptor tyrosine kinases (RTK) was analysed using Proteome 
Profiler Mouse Phospho-RTK Array Kit (R&D systems). Array was used according to man-
ufacturer’s instruction with minor modification. Briefly, lysis buffer was prepared according 
to manual, with the exception that a protease and phosphatase inhibitor cocktail (see list of 
materials) was used. To each thick brain slice 500 µL lysis buffer was added and tissue was 
lysed with a grinding ball at 30 Hz for 2 min (Mixer Mill MM301, Retsch). Lysates were 
incubated on ice for 10 min on a rocking table and centrifuged for 5 min at 16,100xg at 4°C. 
The supernatant was transferred into a new tube and protein concentration was determined 
utilizing Bradford assay (Bio-Rad Protein Assay Dye, Bio-Rad). Protein-concentration 
matched tissue lysates (250 µg total protein) were diluted with array buffer and applied to 
nitrocellulose membranes spotted with capture and control antibodies in duplicates and in-
cubated overnight at 4°C on a rocking table. Membranes were washed to remove unbound 
proteins followed by incubation with an anti-phospho-tyrosine-HRP detection antibody for 
2 h at RT. After washing, phosphorylated tyrosine residues in activated receptors were de-
tected by chemiluminescence using Image Quant LAS 4000 mini machine (GE Healthcare). 
The signal produced by each sport was quantified using Image QuantTL (GE Healthcare) 
software. The signal of a PBS-spot served as control spot and was used as background 
subtraction. Changes in phosphorylation levels of RTK were calculated as the ratio of the 
ipsi- and contralateral hemisphere of the same animal. Tissue of the contra- and ipsilateral 
hemisphere of one animal was applied to membranes of the same batch of an array kit to 
exclude variations within spot densities between batches.  
To ensure induction of cerebral ischemia-related processes, only animals were included 
which showed an increase in the ratio of the phosphorylation level in the ipsilateral hemi-
sphere of more than 1.2 of at least 5 out of 7 RTKs, which were MSPR, PDGFRα, PDGFRβ, 
TrkC, VEGFR1, 2, and 3, indicating an adequate and prototypic ischemic response of the 
tissue at that time point. (see results Figure 21).   
 
3.1.19 Capillary electrophoresis 
Protein levels of EphB2 in lysates used for the Proteome Profiler Array were detected by 
capillary electrophoresis. Capillary electrophoresis (Wes, Protein Simple, Biotechne) was 
used according to manufacturer's instructions. Samples were diluted to a final concentration 
of 0.5 µg/µL. Protein lysates were diluted with 0.1X sample buffer to a final concentration of 
0.5 µg/µL and mixed with 5X Fluorescence master mix according to manufacturer's instruc-
tion. Samples were denaturated for 5 min at 95°C, spun for 1 min at 1000xg, thoroughly 
mixed, and spun for 1 min at 100xg. Antibodies were diluted in Antibody diluent. Volumes 
of diluents were applied to the microplate according to manufacturer's instruction with 
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modification: biotinylated ladder, 5 µL; prepared sample, 5 µL; Wes Antibody Diluent 2, 10 
µL; primary antibody, 9 µL; streptavidin-HRP, 10 µL; secondary HRP conjugate, 9 µL; Lu-
minol-Peroxidase Mix, 15 µL. 
The following setup was used: separation time, 30 min; separation voltage, 375 V; antibody 
diluent time, 5 min; primary antibody time, 30 min; secondary antibody time, 30min. Images 
were automatically analyzed with Compass for SW software. Luminescence was calculated 
as the area under the curve at a specific exposure time (EphB2, 32 s; beta-tubulin, 1 s). 
Protein levels of EphB2 were normalized to those of beta-tubulin.  
 
3.2 Primary cortical cultures 
3.2.1 Coating of culture wells or cover slips for maintenance of neuronal cells  
Wells were covered with poly-D-lysine (2 µg/cm²) and laminin (1 µg/cm²) diluted in sterile 
H2O (for a well of a 24-well plate 500 µL were used) for at least 24 h at 37°C, then washed 
twice with sterile H2O (1 mL per well in a 24-well plate) and stored at 37°C until usage within 
1 week.  
 
3.2.2 Dissection and maintenance 
Primary forebrain neuron cultures were established according to Bading et al (Bading and 
Greenberg, 1991; Bading et al., 1993) with modification. 4-6 neonatal mice were decapi-
tated and brains were removed from skull and further processed in dissection medium on a 
cooling device under a binocular microscope. Hemispheres were separated, meninges, 
midbrain, and hippocampus were removed, the cerebral cortices were isolated and col-
lected in dissection medium on ice. Further steps were performed under a laminar flow. 
Dissection medium was removed and cortices were incubated with 2 times 3 mL enzyme 
solution at 37°C with careful swirling in between. Then, cortices were carefully washed with 
dissection medium (RT) and incubated 3 times with 2 mL inhibitor solution at 37°C. Cortices 
were carefully washed 3 times with 2 mL pre-warmed growth medium (37°C) for 1 min while 
turning the tube consistently by hand for 1 min. Subsequently, 2 mL pre-warmed growth 
medium (37°C) was added and cortices were triturated with a 2-mL serological pipette by 
pipetting up and down for 50 times. 2 mL growth medium were added and cells were allowed 
to stand for 5 min at 37°C. As much as possible of the cell suspension was transported to 
a new tube without any cell clusters. The remaining suspension was triturated as before. 
Finally, cell suspension was triturated a third time with higher pressure to dissolve remaining 
cell clusters. Cell density was determined using a Neubauer counting chamber. Cells were 
diluted in OptiMEM/glucose medium at a density of 125,000 cells/cm² and seeded onto pre-
viously coated 24-well plates (poly-D-lysine (2 µg/cm²) and laminin (1 µg/cm²) diluted in 
sterile H2O for at least 24 h at 37°C, then washed twice with sterile H2O and stored at 37°C 
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until usage within 1 week). Wells were never let get dry and solutions were replaced imme-
diately. After 2.5 h, medium was set to growth medium. Day of plating = day in vitro (DIV) 
0. To inhibit glial cell growth, AraC was added in a final concentration of 2.8 µM on DIV 3. 
On DIV 8 cells were set to so-called transfection medium TM. Experiments were performed 
on DIV 10, when neurons express functional glutamate receptors and have developed an 
extensive network of synaptic contacts.   
All mediums applied to the cells were pre-equilibrated in the respective incubators for at 
least 16 h.  
 
3.2.3 Recombinant adeno-associated viruses (rAAVs).  
The corresponding experiments were done in collaboration with Dr. Anna M Hertle (group 
of Prof Hilmar Bading, Dep of Neurobiology, Heidelberg University). Viral particles were 
produced and purified as described previously (Zhang et al., 2007). Expression of the mito-
chondrially targeted, FRET-based Ca2+ indicator 4mtD3cpv was driven by a viral vector con-
taining a CKIIα promoter. Cells were infected more than 6 h after addition of cytosine-D-
arabinofuranoside (DIV3-4) by applying approx. 1011 rAAV particles per mL.  
 
3.2.4 Fluorescence imaging  
The corresponding experiments were done in collaboration with Dr. Anna M Hertle. All im-
aging experiments were performed RT in a HEPES-buffered saline solution (HBS) contain-
ing, in mM: 140 NaCl, 2.5 KCl, 1.0 MgCl2, 2.0 CaCl2, 10 HEPES, 1.0 glycine, 35.6 D-glu-
cose, and 0.5 C3H3NaO3. Mitochondrial membrane potential and Ca2+ levels and were an-
alyzed as described previously (Hardingham et al., 2002; Palmer & Tsien, 2006; Qiu et al., 
2013) using the FRET-based, mitochondrially targeted Ca2+ indicator, 4mtD3cpv, and the 
small molecule dye, Rh123, respectively. Cytoplasmic calcium levels were determined us-
ing the small molecule dye, Fura-2. Fluorescence images were taken with the following set-
up: upright fluorescence microscope (BX51W1, Olympus), cooled CCD camera at 0.667-
2.0 Hz (iXon, Andor), 20X water-immersion objective (XLMPlanFluor, Olympus), xenon arc 
lamp with an excitation filter wheel (cell^R, Olympus), excitation filters (4mtD3cpv: CFP 
430±12 nm, YFP 500±10 nm; Fura-2: 340±10 nm and 380±10 nm; Rh123: 470±20 nm; AHF 
Analysentechnik), emission filters (Fura-2: 510±20 nm; Rh123: 525±25 nm; 4mtD3cpv: 
470±12 nm and 535±15 nm; AHF Analysentechnik), DualView beam splitter (for 4mtD3cpv; 
MAG Biosystems). 
Images were acquired using cell^R software (Olympus) and further analyzed with Fiji 
(RRID:SCR_02283) and IgorPro (WaveMetrics, RRID:000325).   
Crosstalk- and bleaching-corrected 4mtD3cpv FRET ratios were used to quantify changes 
in mitochondrial calcium concentrations in regions of interest drawn around single neurons 
Methods 
 
 
42 
 
(Palmer and Tsien, 2006). Cells grown on coverslips were loaded with Rh123 (Invitrogen, 
Cat # R302; 4.3 μM) in HBS for 30 min at RT and then extensively washed with HBS. After 
recording, cells were exposed to the mitochondrial uncoupler FCCP (5 µM, Sigma Aldrich) 
to induce maximal Rh123 signal. Detection area of Rh123 fluorescence was limited to the 
nucleus to avoid dequenching artefacts emerging from mitochondria. Fluorescence levels 
were quantified in a cell-by-cell fashion as a% of the maximum Rh123 signal induced by 
FCCP in that cell representing changes in mitochondrial membrane potentials (Ψm). Fluo-
rescence intensities of Fura-2-AM was determined to quantify cytoplasmic calcium levels. 
Cells grown on coverslips were loaded with Fura-2-AM (Molecular Probes, Cat # F1221; 
1 μM; stock solution, 1 mM in 20% Pluronic F-127 (Sigma-Aldrich, Cat # P2443) in DMSO) 
in HBS for 30 min at 37 °C and then extensively washed with HBS. Cytoplasmic calcium 
concentrations were quantified in regions of interest drawn around single neurons. Then, 
the ratio of emission intensities obtained by sequential excitation with 340±10 nm and 
380±10 nm light (340/380 ratio) was determined. 
 
3.2.5 Excitotoxic stimulation  
The corresponding experiments were done in collaboration with Dr. Anna M Hertle. Cells 
were stimulated with Bicuculline (50 μM; negative control) or NMDA (0, 5, 10, 20, or 30 μM) 
for 10 minutes, carefully washed two times with TM, and incubated in fresh TM for a further 
16–24 hours prior to fixation.  
 
3.2.6 Oxygen glucose deprivation (OGD) 
Cells grown in 24-well plates were carefully washed once with medium lacking glucose, 
which was pre-equilibrated in a hypoxic chamber with 1% O2 for at least 16 h and incubated 
with the same medium for 3 h. Control cells received the same medium with glucose equil-
ibrated to standard oxygen levels (~19% O2). After 3 h, cells were either directly fixed or 
washed once with TM and incubated for another 24 h with TM at in a normal cell culture 
incubator.   
 
3.2.7 Cell death analysis (excitotoxic stimulation) 
The corresponding experiments were done in collaboration with Dr. Anna M Hertle. Cells 
were fixed with Roti-Histofix 4% (Carl Roth, Cat # P087) for 15 min RT, washed with PBS, 
and embedded with Mowiol 4-88 mounting medium (Calbiochem) containing 2 μg/mL 
Hoechst 33258 (Serva, Cat # 15090). In each well, 16 evenly distributed fields of view were 
acquired. Images were taken at the Nikon Imaging Center at the University of Heidelberg 
(Ti2 Eclipse inverted microscope (Nikon), Sola SE II Light Engine (Lumencor), S Plan Fluor 
20x objective (NA 0.45; Nikon), and a DS-Qi2 14-bit CCD camera (Nikon), 393±11.5 nm 
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excitation, 447±30 nm emission; Nikon). Images were processed with CellProfiler Software 
by applying custom pipelines to identify nuclei. Amorphous or shrunken nuclei were classi-
fied as dead cells as described previously (Dick and Bading, 2010) and automatically clas-
sified using CellProfiler Analyst software.  
 
3.2.8 Cell death analysis (OGD) 
Cells were washed twice with pre-warmed (37°C) PBS and fixed with 4% PFA and 4% su-
crose in PBS for 15 min at RT. Cells were washed 3 times with PBS-T for 5 min and incu-
bated with 2 µg/mL Hoechst 33258 in PBS for 15 min at RT. After washing twice with PBS 
for 3 min at RT, cells were mounted with Mowiol medium. Images were taken the next day 
with a Zeiss Axiovert 200M microscope with a Hamamatsu ORCA flash 4.0 camera. Wells 
were scanned using TissueFACS software and 11 evenly distributed fields of view of each 
well were examined. Dead cells were identified as above.  
 
3.2.9 Assessment of neuronal cell culture quality 
All steps were performed at RT if not stated otherwise. Purity of cell cultures was tested via 
immunofluorescence staining on DIV10 with a nuclear marker specific for neuronal cells 
(NeuN) and a marker specific for astrocytes (GFAP). Cells grown in a 24-well plate were 
washed twice with pre-warmed PBS (37°C) and fixed with 2% PFA in PBS for 15 min. Then, 
cells were washed 3 times with PBS for 5 min and permeabilized with 0.5% saponin in PBS 
for 10 min. After washing twice with PBS for 3 min, cells were incubated with blocking buffer 
consisting of 0.1% BSA and 0.25% casein in 50 mM Tris followed by incubation with the 
primary antibodies overnight at 4°C. Next day, cells were washed 3 times in TBS-T for 5 
min followed incubation with appropriate secondary antibodies for 1 h. Nuclei were counter 
stained with DAPI. All antibodies were diluted in LowCross-Buffer. Stained cells were then 
embedded in Mowiol mounting medium and stored at 4°C until imaging within 3 days. Flu-
orescence staining was recorded using an Olympus IX51 microscope and a high-resolution 
camera (Olympus). 10 evenly distributed fields of view of each preparation were imaged. 
Nuclei were identified by DAPI-staining. Number of cells showing NeuN-specific fluorescent 
signal were identified as neurons, cells showing GFAP-specific fluorescent signal were iden-
tified as astrocytes. Shrunken nuclei showing high fluorescent intensity of DAPI-staining 
were considered as dead and excluded from quantification. Automatic analysis was per-
formed utilizing TissueGnostics software. Approximately 84% cells were identified as neu-
rons (Figure 6).  
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Figure 6: Neuronal purity 
in cell cultures. Cortical 
neuron cultures were co-
stained at DIV10 with the 
neuron-specific marker 
NeuN and the astrocytic-
specific marker GFAP. At 
least 10 evenly distributed 
FOV of 5 different prepa-
rations (both genotypes) 
were automatically 
counted. Upper line 
shows single channel im-
ages of primary antibody 
staining, lower panel 
shows merged image and 
quantification. Scale bar= 
100 µm. 
 
 
 
 
Figure 7: Expression of 
EphB2 in cultured neu-
rons. Cortical neurons 
were cultured until DIV10 
and single-staining with 
the neuron-specific 
marker MAP2 and an an-
tibody targeted against 
EphB2 was performed. 
Upper panel shows stain-
ing with EphB2, lower 
panel indicates neuronal 
structures by MAP2. 
Small squares are en-
larged in the lower right 
corner of each single-
channel image showing 
neuronal-typical struc-
tures. Scale bar=100 µm. 
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3.2.10 Analysis of expression EphB2 in neuronal cell cultures  
Synthesis of EphB2 was analyzed by performing immunofluorescence staining as described 
above (p 37). Wells with cells from the same preparation were immunofluorescently stained 
for the neuronal marker MAP2. Cells were fixed with zinc-based fixative, permeabilized with 
saponin, and incubated with the primary and appropriate secondary antibody as described 
above (p 22). Nuclei were counterstained with DAPI (1 µg/mL in PBS, 10 min). All antibodies 
were diluted in LowCross-Buffer (Candor). Stained cells were then embedded in Mowiol 
mounting medium (Polysciences) and stored at 4°C until imaging within 3 days. Fluores-
cence staining was recorded using a Zeiss Axiovert 200M microscope with a Hamamatsu 
ORCA flash 4.0 camera. Cortical neurons synthesize EphB2 at DIV10 (Figure 7).   
 
3.3 Statistics 
Data were analyzed using GraphPad Prism 6. Each set of data was tested for normal dis-
tribution. If data were normally distributed, data were tested for outliers by using Grubbs' 
test for outliers. Outliers were removed from the data set. Parametric data sets were tested 
with unpaired, two-sided Student's t-test or Welch's t-test (two groups) or one-way ANOVA 
(more than two groups). Non-parametric data sets were analyzed with Mann-Whitney (two 
groups) test or Kruskal-Wallis test (more than two groups). Multiple comparisons were per-
formed with two-way ANOVA. Tests were post-corrected with Dunn’s (one-way ANOVA, 
Kruskal-Wallis test) or Holm-Sidak method (two-way ANOVA). Data are presented as the 
mean ± standard deviation (SD) if not stated otherwise. Statistical significances are ex-
pressed as p-values with p<0.05 considered as statistically significant difference.    
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4 Results 
 
4.1 Analysis of progression of stroke in Ephb2-deficient mice 
To evaluate the role of the receptor tyrosine kinase Eph receptor B2 (EphB2) during stroke, 
cerebral ischemia was induced by transient middle cerebral artery occlusion (MCAo) for 60 
min in animals without mutations in the Ephb2 gene (described as Ephb2+/+), Ephb2-defi-
cient (Ephb2-/-) and heterozygous mutant mice (Ephb2+/-, 24 h of reperfusion only) followed 
by 48 or 24 h of reperfusion.  
 
 
 
Figure 8: Infarct and edema sizes are reduced in EphB2-defcient mice. Ephb2+/+, Ephb2-/- and 
Ephb2+/- (only 24 h) mice were subjected to 60 min middle cerebral artery occlusion (MCAo) followed 
by 48 (A) or 24 h (B) of reperfusion as indicated. Sagittal brain cryo-sections were Nissl-stained and 
infarct and edema sizes were analyzed using ImageJ. Infarct volume is edema-corrected. Data are 
presented as single values (scatter plots) combined with the mean±SD; (A) N=24/22, Student's t-
test, (B) N=15/17/16, One-way ANOVA, n.s.=not significant 
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After 48 h post the onset of reperfusion, infarct and edema sizes of Ephb2+/+ and Ephb2-
deficient mice were evaluated by measurement of cresyl violet-deficient area in Nissl-
stained brain sections. Ephb2-deficient mice showed a reduction in infarct size of approx. 
37% and in edema size of approx. 40% in comparison to Ephb2+/+ animals (Figure 8A). For 
the analysis after 24 h of reperfusion, Ephb2+/- animals were included to determine a possi-
ble gene-dose effect (Figure 8B). Ephb2-deficient mice showed reduced infarct and edema 
sizes of approx. 28% and 40%, respectively, in comparison to Ephb2+/+ animals. Heterozy-
gous mutants showed a reduction in edema size of 31%, though not significant, while infarct 
size was similar to Ephb2+/+ animals (Figure 8B).  
Further, neurofunctional deficits were assessed. Animals were assigned a score according 
to the Bederson scale (details are described on p33), a readily practicable test since it does 
not require any pre-training of the animals and allows to determine basic neurological defi-
cits. Ephb2-deficient animals were less functionally impaired in comparison to Ephb2+/+ an-
imals after 48 h of reperfusion (Figure 9A). However, after 24 h of reperfusion, no difference 
was observed for Ephb2-deficient and EphB2 heterozygous animals, when compared to 
Ephb2+/+ animals (Figure 9B).  
In addition, motor coordination was tested. Motoric skills were assessed by utilizing the so-
called RotaRod test, which has a high sensitivity to detect motor impairments in ischemic 
models (Schaar 2010). Ephb2-deficient and heterozygous animals showed significantly less 
impairment in motoric skills in comparison to Ephb2+/+ animals. Further, the impairment in 
motoric skills was comparable in Ephb2-deficient and heterozygous mutants (Figure 9C).   
Taken together, the absence of EphB2 attenuated progression of stroke with a possible 
gene-dose effect on neurological function and infarct sizes.  
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Figure 9: Neurological impairment is reduced in Ephb2-deficient mice. Experiments with Ephb2+/+, 
Ephb2-/- and Ephb2+/- ((B)+(C)) mice were performed as described in Figure 8. (A) and (B) Neuro-
logical deficit score was determined according to the Bederson scale. Data are presented as single 
values (scatter plots) combined with the median; (A) N=17/11, (B) N=17/8/15, Kruskal-Wallis test. 
(C) Motoric skills were tested using the Rotarod test before middle cerebral artery occlusion (MCAo) 
and the day afterwards (>16 h of reperfusion). Data are presented as single values (scatter plots) 
combined with the mean±SD; N=5/8/4, Two-way ANOVA, n.s.=not significant.  
 
To analyze the molecular background of the different progression of stroke in greater detail, 
transcriptome analyses of brain lysates of Ephb2-/- and Ephb2+/+ animals were compared. 
Animals were subjected to MCAo followed by 48 h of reperfusion and brain hemispheres 
were separated into an ischemic (ipsilateral) and normoxic (contralateral) hemisphere. The 
samples were then analyzed by DNA microarray and subsequent gene set enrichment anal-
ysis (GSEA). For GSEA, the KEGG database was utilized to identify gene sets clustered in 
signaling pathways.  
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The comparison of the transcriptomes of the ischemic and normoxic hemispheres of 
Ephb2+/+ animals revealed an upregulation of inflammatory, vascular or cell survival gene 
sets. Up-regulated expression of gene sets associated with KEGG pathways was observed 
among others for "ECM-receptor interaction", "Cytokine-cytokine receptor interaction", 
"Leukocyte transendothelial migration", "VEGF signaling pathway", "HIF-1 signaling path-
way", "p53 signaling pathway", and "Apoptosis", which are typically activated in stroke path-
ogenesis (Baeten and Akassoglou, 2011; Doyle et al., 2008; Marti et al., 2000; Wang et al., 
2017; Yilmaz and Granger, 2010). On the other hand, transcripts associated with gene sets 
relevant for pathways involved in the function of neurons were downregulated, such as "Glu-
tamatergic synapse", "GABAergic synapse", "Calcium signaling pathway", and "Nicotine ad-
diction" caused by the loss of neurons after cerebral ischemia (Lee et al., 2000; Won et al., 
2002). Representative pathways including heatmaps of representative genes from each 
pathway are depicted in Figure 10. A complete list of activated pathways is shown in Table 
8, page 87.  
The comparison between the ischemic hemispheres of Ephb2+/+ and Ephb2-deficient ani-
mals showed that transcripts associated with inflammatory, vascular or cell survival path-
ways were less activated in the Ephb2-deficient hemispheres, while transcripts associated 
with pathways describing neuronal function were upregulated in the absence of EphB2 (Fig-
ure 11, Table 9, page 89). The differences in the transcriptomes between the ipsilateral 
hemispheres revealed that cerebral ischemia was attenuated in Ephb2-deficient animals on 
a transcriptional level. 
Finally, the comparison of the contralateral hemispheres of both genotypes identified sev-
eral transcripts associated with pathways in Ephb2-deficient mice which were already dif-
ferently regulated under normoxic conditions. Among others, the transcriptomes of genes 
involved in the pathways "Nicotine addiction" and "Glutamatergic synapse" are not equally 
expressed (Figure 12, Table 10, page 91). Within both pathways, genes encoding subunits 
of the NMDA receptor were differently regulated when compared to Ephb2+/+ normoxic hem-
ispheres, confirming previous studies highlighting the importance of EphB2 for proper 
NMDA receptor function and localization (Henderson et al., 2001; Nolt et al., 2011).  
Taken together, the transcriptome analysis confirmed the attenuation of cerebral ischemia 
in Ephb2-deficient mice on the transcriptional level and further revealed differences in the 
expression of genes encoding products associated with synaptic pathways between the two 
genotypes at a basal level.  
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Figure 10: Transcriptome analysis of Ephb2+/+ mice after stroke. Ephb2+/+ were subjected to 60 min 
middle cerebral artery occlusion (MCAo) followed by 48 h of reperfusion. DNA microarray and gene 
set enrichment analysis of the ipsi- and contralateral hemispheres showed differentially regulated 
pathways (obtained from KEGG database). Representative pathways including example genes are 
depicted here. Expression levels are normalized to row maximal and minimal values. N=3. 
(N)ES=(normalized) enrichment score, FDR=false discovery rate 
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Figure 11: Comparison of transcriptomes upon stroke. Ephb2+/+ and Ephb2-/- mice were subjected 
to 60 min middle cerebral artery occlusion (MCAo) followed by 48 h of reperfusion. DNA microarray 
and gene set enrichment analysis of the ipsilateral hemispheres showed differentially regulated path-
ways (obtained from KEGG database). Representative pathways including example genes are de-
picted here. Expression levels are normalized to row maximal and minimal values. N=3. (N)ES=(nor-
malized) enrichment score, FDR=false discovery rate 
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Figure 12: Comparison of transcriptomes under basal conditions. Ephb2+/+ and Ephb2-/- mice were 
subjected to 60 min middle cerebral artery occlusion (MCAo) followed by 48 h of reperfusion. DNA 
microarray and gene set enrichment analysis of the contralateral hemispheres showed differentially 
regulated pathways (obtained from KEGG database). Representative pathways including example 
genes are depicted here. Expression levels are normalized to row maximal and minimal values. N=3. 
(N)ES=(normalized) enrichment score, FDR=false discovery rate 
 
4.2 Analysis of vascular function in Ephb2-deficient mice 
Vascular function and blood vessel growth play important roles in stroke pathogenesis and 
are influenced by the EphB/ephrin-B system. In mice lacking the Eph receptor ligand ephrin-
B2 vascular, development is disrupted and leads to prenatal death before embryonic day 
11.5 (Adams et al., 1999). To unravel a possible impact of the deletion of EphB2 on the 
vascular system, histological and functional analysis were applied.  
Brain arteries were visualized by transcardial perfusion with a pigment solution that cannot 
penetrate the capillary system. Then, images of the basal vessel structure Circle of Willis 
and the area supplied by the middle cerebral artery were taken. Branches supplying the 
area of the middle cerebral artery and branches directly originating from the middle cerebral 
artery were manually counted. Ephb2+/+ and Ephb2-/- mice exhibited a similar gross anatomy 
of the circle of Willis and the number of artery branches of the middle cerebral artery was 
similar in both genotypes. Intravenous administration of a contrast agent and subsequent 
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µCT scans of two mice from each genotype visualized the venous anatomy of the head and 
did not reveal any gross differences between the genotypes (Figure 13).  
 
 
Figure 13: Cerebrovascular anatomy is not altered in Ephb2-deficient mice. (A) Brain vessels of 
Ephb2+/+ and EphB2-/- mice were visualized with a particle-solution as shown on the right side. 
Branches of the middle cerebral artery were counted in the area indicated with the dotted line. N=6; 
Data are presented as single values (scatter plots) combined with the mean±SD; Mann-Whitney test, 
n.s.=not significant. (B) Ephb2+/+ and Ephb2-/- mice were intravenously injected with a contrast agent 
and scanned with a µCT to visualize large cranial and cervical vessels. 1 = Vena jugularis externa, 2 
= Vena temporalis superficialis, 3 = Vena retromandibularis, 4 = Vena cerebri media, 5 = Vena ba-
salis.  
 
The endothelial marker CD31 and desmin, which labels pericytes, were detected with im-
munofluorescence staining techniques. The CD31-specific fluorescence signal was used to 
calculate the capillary density, while the desmin-specific signal was used to evaluate the 
pericyte coverage of brain vessels. EphB2-/- animals did not show any differences in vessel 
density or pericyte coverage of brain vessels when compared to Ephb2+/+ mice (Figure 14). 
Though Ephb2-deficient mice did not show any histologic differences in the vascular sys-
tem, the function of Ephb2-defcient endothelial cells might have been altered in comparison 
to Ephb2+/+ mice and was therefore analyzed in more detail. 
Cerebrovascular anatomy
Ephb2 +/+Ephb2 -/-
0
5
10
15
20
25 n.s.
A
Ephb2+/+ Ephb2-/-
B
Ephb2+/+ Ephb2-/-
1
2
5
43
1
2
5
4
3
br
an
ch
es
M
C
A
ar
ea
Results 
 
 
54 
 
The reduction in regional cerebral blood flow (rCBF) during MCAo was measured by a laser-
Doppler probe as an increased blood supply could lead to less severe infarctions in Ephb2-
deficient mice. However, the reduction in rCBF was similar in both genotypes (Figure 15A), 
indicating that the reduction in infarct and edema volumes seen in Figure 8 cannot be ex-
plained by a reduced induction of cerebral ischemia per se.  
Disruption of endothelial tight junctions and rearrangement of tight junctional proteins such 
as ZO-1 are hallmarks of I/R injury. Subsequently, junctional integrity is impaired, thereby 
increasing blood-brain barrier (BBB) paracellular permeability which leads to vasogenic 
edema formation. 
 
 
 
Figure 14: Brain vessel characteristics are comparable in Ephb2+/+ and Ephb2-/- mice. CD31 and 
desmin were detected with immunofluorescence staining techniques in sagittal cryo-sections of 
brains of Ephb2+/+ and Ephb2-/- mice. (A) Number of CD31-positive vessels per mm² and representa-
tive images. (B) Pericyte coverage of brain vessels representative images. Representative images 
were digitally enhanced for better clarity. N=4; Data are presented as single values (scatter plots) 
combined with the mean±SD; Mann-Whitney test, n.s.=not significant. Scale bar=100 µm.  
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Figure 15: Endothelial permeability is not altered. Ephb2+/+ and Ephb2-/- mice were subjected to 
middle cerebral artery occlusion (MCAo) followed by reperfusion as indicated. (A) Just before occlu-
sion of the middle cerebral artery and immediately after occlusion, regional cerebral blood flow (rCBF) 
was measured using a laser-Doppler-probe on the skull of the mouse. N=6; Mann-Whitney test. (B) 
Evans Blue was injected via the tail vein. Evans Blue extravasation in each hemisphere was meas-
ured by absorption. 12 h: N=3/4; 24 h: N=9/8, Two-way ANOVA. (C) CD31 and ZO-1 were detected 
with immunofluorescence staining techniques in sagittal brain cryo-sections of of Ephb2+/+ and 
Ephb2-/- mice. Cortex (periinfarct) and striatum (infarct core) were separately analyzed. N=4, Kruskal-
Wallis test. (A)-(C): Data are presented as single values (scatter plots) combined with the mean±SD. 
n.s.=not significant. (D) Representative image for analysis in (C). Gaps (arrow head) in ZO-1 staining 
were counted in brain vessels. Scale=10µm. 
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BBB permeability was first assessed with the well-established Evans Blue assay. Here, the 
fluorescent dye Evans Blue is intravenously injected shortly before the end of reperfusion 
after MCAo. Because of its high affinity to serum albumin, an increase in BBB permeability 
can be measured as serum albumin only leaks into the brain parenchyma when the BBB is 
impaired. The assay showed an increase in Evans Blue content in the ipsilateral hemisphere 
upon stroke after 24 h, but not after 12 h of reperfusion. However, at both time points, the 
Evans Blue content in the ipsilateral hemispheres was similar in both genotypes (Figure 
15B). 
 
 
 
Figure 16: Vasogenic edema formation is reduced after 24 h of reperfusion in Ephb2-deficient mice. 
Ephb2+/+ and Ephb2-/- mice were subjected to 60 min middle cerebral artery occlusion (MCAo) fol-
lowed by 6 h and 24 h of reperfusion. High-resolution MRI at 9.4T was performed with a T2-weighted 
set-up. (A) T2-weighted volume indicates vasogenic edema size. N=8-9, Data are presented as sin-
gle values (scatter plots) combined with the mean±SD, Two-way ANOVA, n.s.=not significant. (B) 
Representative image. 
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Next, gap formation in tight junctions was analyzed by counting the numbers of interruption 
in the ZO-1-specific fluorescent signal in striatum and cortex. Though this method showed 
an increase in gaps in tight junctions after 24 h of reperfusion in the ipsilateral striatum when 
compared to the contralateral region as expected, there was no difference between the two 
genotypes at any time point of in any brain region measured (Figure 15C).  
Taken together, the paracellular leakage through the BBB and the rearrangment of endo-
thelial junctional proteins were not different in the absence of EphB2.The post-mortem anal-
ysis regarding edema formation (Figure 8) revealed differences in the total edema volume 
between the two genotypes. However, the methods used so far to show the reduction in 
brain swelling in Ephb2-deficient mice did not differ between the two types of edema for-
mation induced by stroke. The vasogenic edema is mainly caused by disruption of the BBB 
leading to extravasation and extracellular accumulation of fluid in the cerebral parenchyma. 
In contrast, cytotoxic edema does not involve dysfunction of endothelial permeability but is 
caused by an accumulation of ions in the intracellular space followed by massive influx of 
water. Subsequently, cells undergo swelling. Though cytotoxic edema formation itself does 
not induce addition of water mass into the brain parenchyma, it promotes vasogenic edema 
formation which finally results in brain swelling. By utilizing magnetic resonance imaging 
(MRI) with an imaging protocol including T2 relaxometry and diffusion-weighted imaging, it 
is possible to evaluate and differentiate between vasogenic and cytotoxic edema formation 
in the hyperacute phase (6 to 24 h post-MCAo) in vivo and in a longitudinal fashion.  
To this end, mice were scanned 6 and 24 h after MCAo. The T2-weighted set-up was used 
to calculate the vasogenic edema, while diffusion-weighted imaging allowed to evaluate the 
formation of the cytotoxic edema by measurement of the apparent diffusion coefficient 
(ADC). T2-weighted volumes were measured in the whole ipsilateral hemisphere, in the 
cortex and in the basal ganglia which include the striatum. MRI scans confirmed an increase 
in all volumes in all areas from 6 to 24 h (Figure 16) as expected from other studies (Barber 
et al., 2005; Gerriets et al., 2009; Henninger et al., 2006; Zhang et al., 2016).  
The volume of the vasogenic edema in the Ephb2-deficient mice was smaller after 24 h 
compared to Ephb2+/+ mice, though not significantly (p=0.0542). Next, cortex and striatum 
were analyzed in greater detail as the cortex represents an area which is later affected upon 
stroke, while the striatum represents the infarction core. The comparison between the two 
genotypes did not show a difference in the T2-weighted volumes in the cortex at any time 
point. However, a significant reduction of 23% in the striatum of Ephb2-deficient mice after 
24 h of reperfusion was observed. 
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Figure 17: Cytotoxic edema formation is reduced after 6 h of reperfusion in Ephb2-deficient mice. 
Ephb2+/+ and Ephb2-/- mice were subjected to 60 min middle cerebral artery occlusion (MCAo) fol-
lowed by 6 h and 24 h of reperfusion. Diffusion-weighted imaging was performed with a high-resolu-
tion MRI at 9.4T. (A) Apparent diffusion coefficient (ADC)-derived lesion volume indicates cytotoxic 
cell swelling. N=8-9, Data are presented as single values (scatter plots) combined with the mean±SD, 
Two-way ANOVA, n.s.=not significant. (B) Representative images. 
 
The ADC-derived lesion volume increased over time as it was already shown for the vaso-
genic edema. ADC-derived lesion volumes (Figure 17) in the whole ipsilateral hemispheres 
were reduced by 29% in Ephb2-deficient mice after 24 h of reperfusion, but not during the 
hyperacute phase 6 h after stroke. The cytotoxic edema did not differ in the cortex at any 
time point measured. However, in the striatum, the cytotoxic edema was already signifi-
cantly smaller by 25% in the Ephb2-/- mice after 6 h and also later after 24 h of reperfusion.  
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Taken together, the results suggest that less cytotoxic edema evolves in the absence of 
EphB2 in the hyperacute phase after stroke (6 h of reperfusion), while the vasogenic edema 
develops to a similar extent after 6 h of reperfusion. 
 
4.3 Evaluation of cytotoxic effects in Ephb2-defcient mice 
The results shown in Figure 16 and Figure 17 insinuate that the attenuation in progression 
of stroke in the absence of EphB2 was not caused by a dysregulation of endothelial function 
in Ephb2-/- mice but rather by a reduction of cytotoxic effects in the early phase after stroke.  
 
 
 
Figure 18: Infarct and edema sizes differ already 12 h after reperfusion. Ephb2+/+, Ephb2-/- and 
Ephb2+/- mice were subjected to 60 min middle cerebral artery occlusion (MCAo) followed by 12h of 
reperfusion. (A) Infarct and edema volumes were determined in Nissl-stained brain sections as in 
Figure 8. Data are presented as single values (scatter plots) combined with the mean±SD; N=6/5/6; 
One-way ANOVA test. (B) Animals were treated as in (A). Neurological deficit score was determined 
as described in Figure 9. Data are presented as single values (scatter plots) combined with the me-
dian; N=8/6/11; Kruskal-Wallis test, n.s.=not significant.  
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Therefore, the infarct volumes were determined earlier than 24 h of reperfusion. As cresyl 
violet staining is not sensitive enough to enable identification of an infarction at 6 h after 
stroke, infarct volume was determined at 12 h after stroke.  
Both Ephb2-deficient and Ephb2 heterozygous mutants showed significantly decreased in-
farct volumes 12 h after stroke. The edema volume determined by Nissl staining showed a 
difference between Ephb2+/+ and Ephb2-/- mice. Neuronal function determined by Bederson 
scale, which was developed to show successful infarction after 24 h, was not different be-
tween the three genotypes.  
 
 
 
Figure 19: Neuronal degeneration is attenuated in Ephb2-deficient mice. Ephb2+/+ and EphB2-/- mice 
were subjected to 60 min middle cerebral artery occlusion (MCAo) followed by 12 h of reperfusion. 
Degenerative neurons in brain cryo-sections were labeled by Fluoro-Jade C (FJC) staining. Data are 
presented as single values (scatter plots) combined with the mean±SD; N=6; Student's t-test. (B) 
Representative images of ipsi- and contralateral regions after FJC staining. Representative images 
were digitally enhanced for better clarity Scale bar=100 µm. 
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Next, the neuronal degeneration was determined in cryo-sections of Ephb2+/+ and Ephb2-/- 
mice 12 h after stroke. Neuronal degeneration is a process leading to the loss of function 
and/or death of neurons and was determined by Fluoro Jade C staining, which is a fluoro-
chrome specifically labeling neurons undergoing neurodegeneration (Schmued and 
Hopkins, 2000). Neuronal degeneration was reduced in the whole ipsilateral hemisphere in 
Ephb2-deficient mice when compared to Ephb2+/+ mice, though not significantly. Neuronal 
degeneration was similar in both genotypes in the infarction core, the striatum, 12 h after 
stroke. However, in the cortex, an area which is later affected, neuronal degeneration was 
significantly reduced in the Ephb2-deficient mice compared to control mice.  
Taken together, neuronal degeneration in the cortex was already reduced in the hyperacute 
phase (12 h of reperfusion) in Ephb2-deficient mice.  
 
4.4 EphB2 activation in the early hyperacute phase after stroke  
The Ephb2-deficient mutant mice used in this study has developmental defects as described 
previously (Grunwald et al., 2001; Henderson et al., 2001; Henkemeyer et al., 1996). The 
observed attenuation of progression of stroke could be explained by an overall different pre-
conditioning of these mice caused by developmental differences rather than by an involve-
ment of EphB2 in stroke pathogenesis in general.  
Activation of EphB2 and subsequent signal induction can be determined by its phosphory-
lation. To this end, brain lysates of Ephb2+/+ mice subjected to MCAo followed by 6 h of 
reperfusion were applied to a protein array to assess phosphorylation levels of 39 different 
murine receptor tyrosine kinase (RTK) proteins including members of the Eph receptor fam-
ily. 
Phosphorylation of EphB2 was significantly increased in the ipsilateral hemispheres, indi-
cating an involvement of EphB2 in stroke pathogenesis. At 6 h after reperfusion, the overall 
abundance of EphB2 is not reduced in the ipsilateral hemisphere as shown by immunoflu-
orescence staining techniques and measurement of protein levels in brain lysates. How-
ever, EphB2 abundance decreased over time according to the loss of neurons (Figure 20). 
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Figure 20: EphB2 is phosphorylated in the early hyperacute phase upon stroke. (A) Ephb2+/+ mice 
were subjected to 60 min middle cerebral artery occlusion (MCAo) followed by 6 h of reperfusion. 
Brains were divided into contralateral (normoxic) and ipsilateral (ischemic) hemispheres and applied 
to proteome profiler membranes (protein-concentration matched amounts) for detection of phosphor-
ylation levels of EphB2 (pEphB2). Ratio of pEphB2 levels in the ipsi- vs. the contralateral hemisphere 
was calculated and compared to ideal control (ctrl). N=6, mean±SD, Student's t-test with Welch's 
correction. (B) Lysates from (A) were analyzed by capillary electrophoresis for detection of EphB2-
levels. N=3, mean±SD, Mann-Whitney test, n.s.=not significant. (C) Peak analysis of Simple Western 
analysis software. (E) Mice were treated as in Figure 15C. Representative images showing detection 
of EphB2 in cryo-sections by applying immunofluorescence-based techniques. Dotted line indicates 
border of infarcted are. Grey line in lower right panel indicates tissue border. Scale=5mm.  
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4.5 Involvement of further members of the EphB/ephrin-B family in the hy-
peracute phase after stroke 
The evaluation of the phosphorylation levels of RTKs revealed that many RTKs are acti-
vated after cerebral ischemia (Figure 21 and Figure 22). For instance, phosphorylation of 
macrophage-stimulating protein receptor (MSPR), platelet-derived growth factor receptor 
(PDGFR) alpha and beta, tropomyosin receptor kinase C (TrkC) and VEGF receptors was 
increased and used as identification of an adequate cerebral ischemia, since the activation 
of these proteins have already been shown to be involved in cerebral ischemia or similar 
brain insults (Renner et al. 2003; Suzuki et al. 2008; Ma et al. 2011; Greenberg & Jin 2013; 
Chung et al. 2017). 
 
 
 
Figure 21: Phosphorylation levels of various RTKs (without Eph receptors) are elevated upon cere-
bral ischemia. Ephb2+/+ mice were subjected to 60 min middle cerebral artery occlusion (MCAo) fol-
lowed by 6 h of reperfusion. Brains were divided into contra-(non-ischemic) and ipsi-(ischemic)lateral 
hemispheres and applied to proteome profiler membranes for detection of phosphorylation levels of 
receptor tyrosine kinases. RTKs, which were selection-criteria for successful induction of cerebral 
ischemia are highlighted in dark grey. N=6, mean±SD, Student's t-test with Welch's correction.  
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Figure 22: Phosphorylation levels of Eph receptors are increased upon cerebral ischemia. Ephb2+/+ 
mice were subjected to 60 min middle cerebral artery occlusion (MCAo) followed by 6 h of reperfu-
sion. Brains were divided into contralateral (non-ischemic) and ipsilateral (ischemic) hemispheres 
and applied to proteome profiler membranes for detection of phosphorylation levels of receptor tyro-
sine kinases. EphB2 is highlighted as this data point is also depicted in Figure 20. N=6, mean±SD, 
Student's t-test with Welch's correction. *: p<0.05. 
 
 
MCAo did not only induce phosphorylation of EphB2 but also of other Eph receptors under-
lining the importance of the Eph receptor family in stroke pathogenesis. Phosphorylation 
levels of EphB4 and EphB6 were significantly elevated in the ipsilateral hemisphere. EphA1, 
2, 3, 6, 7 and 8 also showed increases in phosphorylation levels, however, not significantly 
(Figure 22). In addition to EphB2 (Figure 20), expression levels of EphB2 ligands, ephrin-
B1 and ephrin-B2, were analyzed in cryo-section 6 and 24 h after MCAo. Immunofluores-
cence staining showed a similar decay of ephrin-B1- and ephrin-B2-specific intensity after 
24 h of reperfusion in the ipsilateral hemisphere in both genotypes. Fluorescence intensity 
specific for the Eph receptor EphB4, which is mainly expressed on veins, declined only 
slightly (Figure 23).  
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Figure 23: Immunofluorescent staining of members of the EphB/ephrin-B family. Ephb2+/+ and       
EphB2-/-  mice were subjected to 60 min middle cerebral artery occlusion (MCAo) followed by 6 h or 
with 24 h of reperfusion. EphB4, ephrin-B1 and ephrin-B2 were detected with immunofluorescence 
staining techniques in sagittal cryo-sections of brains of Ephb2+/+ and Ephb2-/- mice. Representative 
images were digitally enhanced for better clarity. Dotted line indicates border of infarct obtained from 
corresponding Nissl-stained cryo-sections. Corresponding immunofluorescence staining of EphB2 is 
shown in Figure 20. Scale bar=5mm. 
 
4.6 Analysis of NMDA receptor function in Ephb2-deficient neurons 
Excessive release of glutamate into the extracellular space and subsequent overactivation 
of NMDA receptors is a crucial step in the ischemic cascade. Previous studies already 
showed an impact of the Eph receptor EphB2 on NMDA receptor function (Dalva et al., 
2000; Grunwald et al., 2001; Henderson et al., 2001; Nolt et al., 2011; Takasu et al., 2002). 
Activation of EphB2 with ephrin-B ligands induce interaction of EphB2 with the NMDA re-
ceptor subunit NR1 and phosphorylation of another subunit of the NMDA receptor, NR2B. 
This phosphorylation is required for Ca2+ influx through the NMDA receptor and induction of 
further signaling processes (Dingledine et al., 1999). It was already shown that Ephb2-
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defcient neurons exhibit reduced NMDA receptor-mediated signaling (Dalva et al., 2000). 
The results from previous studies suggest that activation of EphB2 with ephrin-B ligands 
modulates Ca2+ influx through the NMDA receptor in neurons. NMDA receptor overstimula-
tion leads to an increase in cytoplasmic calcium as well as accumulation of calcium in mito-
chondria, and further to depolarization of the mitochondrial membrane potential which even-
tually causes cell death (Stanika et al., 2009a). Considering the importance of NMDA re-
ceptor-mediated excitotoxicity during cerebral ischemia, the next part of this study aimed at 
analyzing the function of NMDA receptors in Ephb2-deficient neurons in the context of ex-
citotoxicity.   
To this end, primary cortical cultures, mainly consisting of neurons (>80% Figure 1), were 
isolated from newborn (P0) brains of Ephb2+/+ and Ephb2-/- mice and cultured for 10 days. 
At the tenth day in vitro (DIV10), neurons express EphB2 receptors (Figure 7) and functional 
glutamate receptors, are susceptible to NMDA-induced excitotoxicity (Fogal et al., 2005) 
and have developed an extensive network of synaptic contacts (Verderio et al., 1999). Cy-
toplasmic and mitochondrial Ca2+ levels as well as changes in mitochondrial membrane 
potentials were evaluated before and after NMDA receptor stimulation.  
 
 
 
Figure 24: Cytoplasmic Ca2+ levels are not altered upon NMDA receptor stimulation. Ephb2+/+ and 
Ephb2-/- forebrain neurons were obtained from P0 mice. Cytoplasmic Ca2+ imaging performed in con-
trol conditions (A) and brief (30 s) stimulation with 20 µM NMDA signal (B). N=15/16 cover slips from 
4 independent preparations. Data are presented as single values (scatter plots) combined with the 
mean±SD, Student's t-test, n.s.=not significant. 
 
Ca2+ imaging using the ratiometric indicator Fura-2 was performed to examine global cyto-
plasmic Ca2+ levels at baseline and during selective stimulation of NMDA receptors. Neither 
baseline 340/380 fura-2 ratios (in the presence of inhibitors of voltage-dependent Ca2+ 
Ephb2+/+Ephb2 -/-
Cytoplasmic Ca2+
baseline
0.0
0.2
0.4
0.6
0.8
1.0
1.2
n.s.
Ephb2 +/+Ephb2 -/-
Cytoplasmic Ca2+
NMDA - amplitude
0.0
0.5
1.0
1.5
n.s.
A B
b
a
s
a
l
F
u
ra
-2
3
4
0
/3
8
0
ra
ti
o
in
c
re
a
s
e
in
l
F
u
ra
-2
3
4
0
/3
8
0
ra
ti
o
Results 
 
 
67 
 
channels, AMPA receptors, and voltage-dependent sodium channels to prevent AP bursts 
and associated Ca2+ signals) nor the amplitudes of indicator responses to brief (30 s) stim-
ulation with 20 µM NMDA were different between the two genotypes. These results indicate 
that NMDA receptor-mediated cytoplasmic Ca2+ signaling is not grossly affected by the ab-
sence of Ephb2 (Figure 24) in cultured neuronal cells.  
 
 
 
Figure 25: Ephb2-deficient mice have reduced NMDA receptor-dependent mitochondrial Ca2+ levels. 
Ephb2+/+ and Ephb2-/- forebrain neurons were obtained from P0 mice. Mitochondrial calcium imaging 
performed with drugs in the bath to inhibit voltage-dependent calcium channels, AMPA receptors, 
and voltage-dependent sodium channels. This should prevent action potentials and all associated 
calcium signals, leaving the "pure" NMDA signal, which is evoked by a brief (30 s) application of 
20 µM NMDA. Mitochondrial calcium levels after application of inhibitors (A) and after NMDA stimu-
lation (B). N=15/19 cover slips from 4 independent preparations. Data are presented as single values 
(scatter plots) combined with the mean±SD, Student's t-test. (C) Representative data for 1 cover slip 
each of Ephb2+/+ and Ephb2-/- cells. Data are mean±SEM) N=15/19 cover slips from 4 independent 
preparations. 
Ephb2+/+Ephb2 -/-
Mitochondrial Ca2+
NMDA amplitude
0.0
0.5
1.0
1.5
2.0
p<0.0001
A B
C
Ephb2 +/+ Ephb2 -/-
Mitochondrial Ca2+
baseline (inhibitors)
0.0
0.5
1.0
1.5
2.0 p<0.0001
b
a
s
a
l
4
m
tD
3
c
p
v
F
R
E
T
ra
ti
o
in
c
re
a
s
e
in
4
m
tD
3
c
p
v
F
R
E
T
ra
ti
o
0 120 240 360 480 600
1.0
1.5
2.0
2.5
3.0
3.5
time (s)
Mitochondrial Ca2+ NMDA action potential burst
NMDA
TTX + nifedipine + verapamil + NBQX
Ephb2+/+
Ephb2-/-
4
m
tD
3
c
p
v
F
R
E
T
ra
ti
o
Results 
 
 
68 
 
To measure mitochondrial Ca2+ levels, cells were infected with rAAVs driving the expression 
of a FRET-based Ca2+ indicator (4mtD3cpv) targeted to mitochondria. As previously, cells 
were treated with drugs inhibiting voltage-dependent Ca2+ channels, AMPA receptors, and 
voltage-dependent sodium channels to prevent APs and associated Ca2+ signals. Subse-
quently, cells were briefly stimulated with 20 µM NMDA thereby evoking an almost pure 
NMDA signal. Treatment with the inhibitors already resulted in a decreased baseline of the 
FRET ratio in Ephb2-deficient neurons. Further, the increase in the FRET ratio was signifi-
cantly reduced in Ephb2-deficient neurons when compared to Ephb2+/+ neurons (Figure 25). 
This suggests that the mitochondrial Ca2+ homeostasis regulated by NMDA receptors is 
impaired already under baseline conditions when EphB2 is absent, and to an even greater 
extent when NMDA receptors are stimulated.  
 
As excessive NMDA receptor stimulation is known to promote cell death via breakdown of 
the mitochondrial membrane, the next experiments aimed at identifying whether and how 
the absence of EphB2 may alter mitochondrial membrane potential responses to NMDA 
receptor -stimulation. To these ends, cells were loaded with the fluorescent dye Rhodamine 
123 (Rh123). Due to its positive charge, Rh123 accumulates under basal conditions within 
the mitochondrial matrix, where its high concentration leads to quenching. Mitochondrial 
membrane depolarization induces leakage of Rh123 from the mitochondria into the cyto-
plasm, where its fluorescence is dequenched resulting in intensive fluorescent intensity 
(Baracca et al., 2003). Exposing neurons to the mitochondrial uncoupler FCCP results in 
maximum fluorescence intensity of Rh123 and signal intensities of Rh123 are expressed 
as% of the maximum. Neurons were stimulated with 5 or 20 µM NMDA and changes in 
Rh123 fluorescence intensity during the subsequent 9 min were quantified. Stimulation with 
low-dose NMDA did not lead to changes to in the Rh123 intensity and did not reveal differ-
ences between the two genotypes. However, when cells were treated with 20 µM, Ephb2-
deficient neurons showed a significantly smaller increase in Rh123 intensity when com-
pared to Ephb2+/+ neurons indicating that Ephb2-deficient neurons are less susceptible to 
NMDA-induced mitochondrial membrane depolarization (Figure 26). 
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Figure 26: Mitochondrial membrane potential imaging. (A) Quantification of the area under the curve 
during the first 9 minutes of NMDA treatment for 5 and 20 µM NMDA. (B) Representative data for 1 
cover slip each of Ephb2+/+ and Ephb2-/- cells during stimulation with 20 µM NMDA over ~10 
minutes. N=10 cover slips (5 µM), N=16/22 cover slips from 4 independent preparations. Data are 
presented as single values (scatter plots) combined with the mean±SD, Student's t-test, n.s.=not 
significant. 
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4.7 Ca2+ rises during action potential bursts are slightly attenuated in 
Ephb2-deficient neurons 
Synaptic activity can trigger a nuclear Ca2+-driven neuroprotective gene program leading to 
a reduction in excitotoxicity-associated mitochondrial Ca2+ load (Depp 2017). Consequently, 
neurons are less sensitive to excitotoxicity-mediated cell death (Depp 2017, Tauskela 
2008). AP bursting was triggered by treatment with the GABAa receptor antagonist gaba-
zine and cytoplasmic Ca2+ responses were measured with Fura-2 as above.  
The amplitudes of cytoplasmic Ca2+ responses to a single burst of action potentials were 
attenuated in Ephb2-deficient neurons (Figure 27). However, mitochondrial Ca2+ levels, 
which were measured as before, were not different during action potential burst (Figure 28).  
Taken together, these data show both attenuated NMDA receptor -dependent mitochondrial 
Ca2+ signaling and diminished sensitivity of the mitochondrial membrane potential to NMDA 
receptor stimulation in Ephb2-deficient neurons.  These findings support the hypothesis that 
Ephb2-deficient neurons might be protected from NMDA-induced excitotoxicity.   
 
 
 
Figure 27: Cytoplasmic Ca2+ levels during AP burst. Ephb2+/+ and Ephb2-/- forebrain neurons were 
obtained from P0 mice. Cytoplasmic calcium imaging performed in control conditions (A) and after 
action potential burst triggered by GABAa receptor antagonist gabazine, halted by TTX (B). N=8/15 
cover slip from 4 independent preparations. Data are presented as single values (scatter plots) com-
bined with the mean±SD, Student's t-test, n.s.=not significant. 
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Figure 28: Mitochondrial Ca2+ levels during AP burst are not different. Ephb2+/+ and Ephb2-/- forebrain 
neurons were obtained from P0 mice. Mitochondrial calcium imaging, action potential burst triggered 
by GABAa receptor antagonist gabazine, halted by TTX. (A) Mitochondrial calcium levels in control 
conditions. (B) Amplitude of AP-triggered mitochondrial calcium rises. N=13/15 CS from 4 independ-
ent preparations. Data are presented as single values (scatter plots) combined with the mean±SD, 
Student's t-test, n.s.=not significant. (C) Representative data for 1 cover slip each of Ephb2+/+ and  
Ephb2-/- cells. Data are mean±SEM.  
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4.8 Excitotoxic NMDA receptor stimulation does not induce different levels 
of cell death in the absence of EphB2 
To evaluate the influence of NMDA on excitotoxicity in greater detail, neurons from Ephb2+/+ 
and Ephb2-/- mice were stimulated with increasing concentrations of NMDA (no inhibitors 
applied). 
 
 
 
Figure 29: Neuronal cell death upon excitotoxic stimuli. Ephb2+/+ and EphB2-/- forebrain neurons 
were obtained from P0 mice. (A) Cells were stimulated with Bicculin (Bic, as negative control) or 
different NMDA concentrations as indicated. Fraction of dead cells was determined 24 h after stimu-
lation. N=10/8 cover slips from 4 independent preparations. (B) and (C) Cells were subjected to 3 h 
oxygen-glucose deprivation (OGD). Fraction of dead cells was determined immediately afterwards 
(B) or 24 h afterwards (C) and compared to control conditions (ctrl). N=4, data are presented as 
single values (scatter plots) combined with the mean±SD, Two-way ANOVA, n.s.=not significant.    
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The fraction of dead cell was determined 24 h later by automatic evaluation of nuclear mor-
phology visualized by Hoechst staining. Although there was a successful induction of cell 
death at 30 µM NMDA, there was no difference between the two groups of neurons (Figure 
29A). To mimic cerebral ischemia in vitro, cells were subjected to oxygen-glucose depriva-
tion (OGD) for three hours. Control cells were incubated under the same conditions but with 
glucose and normal oxygen levels. Cells were either directly stained with Hoechst dye af-
terwards or reoxygenated in normal growth medium for another 24 h before staining with 
Hoechst. The fraction of dead cells was automatically determined as before according to 
the morphological appearance of the nuclei. There was sufficient induction of cell death 
already after 3 h of OGD. However, the levels of cell death did not differ between the two 
genotypes at any time point measured (Figure 29B). 
 
 
Annotation regarding shared data usage 
 
In accordance with the guidelines for animal welfare and implementation of the three Rs in 
experimental protocols, the following in vivo data were generated together with Laura-Inés 
Böhler and will also be found in her doctoral thesis: 
- infarct and edema sizes Figure 8 and Figure 18 
- neurological deficits Figure 9 and Figure 18 
- cerebrovascular anatomy Figure 13 
- endothelial permeability Figure 15A and B 
- MRI scans Figure 16 and Figure 17 
- raw data obtained from transcriptome analysis  
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5 Discussion 
5.1 Progression of stroke is attenuated in Ephb2-deficient mice  
According to the world health organization, stroke is the second most common cause of 
death worldwide and the primary cause of disability in adults in the Western world. Despite 
intensive research, the pathophysiological mechanisms are not fully understood, and no 
causative therapy is available. The current therapy in humans aims at fastest possible res-
toration of cerebral blood flow by drug-induced thrombolysis with tissue plasminogen acti-
vator or mechanical removal of the thrombus occluding the brain artery (Powers et al., 
2018). In contrast to human ischemic strokes, animal stroke models, such as the MCAo in 
rodents, are reproducible, controllable and allow investigation of the molecular pathomech-
anisms especially during the first hours upon cerebral ischemia. The degree of the progres-
sion of stroke highly depends on the duration of the MCAo. The longer the rCBF is inter-
rupted, the larger the final damage to the brain tissue becomes (Carmichael, 2005). It is 
suggested that the infarct volume increases until 24 h after MCAo followed by reperfusion 
and remains relatively stable until 7 days afterwards. During the first 6 h after MCAo, the 
infarct is limited to regions in the striatum. Therefore, the striatum is considered as infarct 
core. After 12 h, the whole striatum is infarcted and tissue damage becomes also visible in 
the cortex. Due to limited regenerative capacity tissue damage in the infarct core is unlikely 
to be salvageable at any time point later than 12 h after cerebral ischemia followed by im-
mediate reperfusion as suggested by several studies (Clemens et al., 1998; Liu et al., 2009; 
Reglodi et al., 2000). 
This study is the first one to show that the RTK EphB2 is involved in the early progression 
of stroke shedding further light on the molecular mechanism of EpB2-related stroke patho-
genesis. In Ephb2-deficient mice, brain tissue injury and motoric impairments were clearly 
reduced 24 h upon MCAo confirming that the lack of EphB2 attenuates the progression of 
stroke. In line with the aforementioned facts, a time-course analysis revealed that infarct 
volumes of Ephb2-deficient mice were already reduced after 12 h of reperfusion when com-
pared to Ephb2+/+ mice. Ephb2+/- mice also developed less brain tissue injury and showed 
less impaired motoric skills when compared to Ephb2+/+ mice indicating a gene-dose effect 
of EphB2 on stroke progression. While neuronal degeneration in the infarct core was not 
different between Ephb2+/+ and Ephb2-/- mice, neuronal degeneration in the cortex was di-
minished in Ephb2-deficient mice indicating decreased spatial spread of cellular depolari-
zation and subsequent neuronal cell death induction (Lee et al., 2000) in Ephb2-/- mice.  
For the first time, this study shows that a member of the Eph/ephrin family influences the 
progression of stroke during the first 6 h. So far, studies mainly investigated the involvement 
of Eph or ephrin proteins during later phases upon stroke (24 h – 4 weeks). The later phases 
upon stroke are hallmarked by regenerative processes, such as angiogenesis and 
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neurogenesis (Ruan et al., 2015; Xiong et al., 2010). In this context, it was shown that the 
ligand ephrin-B2, which also interacts with EphB2 (Kullander and Klein, 2002), is involved 
in the restoration of the BBB and neurovascular repair mechanisms upon cerebral ischemia. 
Enhanced activation of ephrin-B2 improved neurovascular repair mechanisms by increased 
pericyte recruitment after MCAo. However, the authors suggested that this mechanism is 
mediated by the interaction of ephrin-B2 with EphB4 and that this interaction would influence 
the angiopoietins/Tie2 system in endothelial cells and pericytes (Ghori et al., 2017). In an-
other study, it was shown that infarct volumes were increased in mice lacking the EphB-
ligand ephrin-B3. Surprisingly, post-ischemic neurogenesis, which usually improves neuro-
logical function upon cerebral ischemia (Gonzalez et al., 2007; Ishibashi et al., 2007), was 
enhanced but could not contribute to functional recovery of these mice (Doeppner et al., 
2011). Induction of post-ischemic neurogenesis is mediated by enhanced proliferation and 
migration of progenitor cells in the subventricular zone (Palma-Tortosa et al., 2017; Zhang 
et al., 2008). Conover and colleagues suggested that blockage of EphB2/ephrin-B signaling 
induces enhanced cell proliferation and disrupted neuroblast migration in the SVZ (Conover 
et al., 2000). Further, hypertensive stroke-prone rats treated with EphB2-Fc protein showed 
improved neurological function as well as enhanced cell proliferation in the SVZ 3 weeks 
after permanent MCAo. The authors claimed that the administration of EphB2-Fc blocks 
endogenous EphB2 signaling as it interacts with available ephrin-B ligands. The interruption 
of EphB2 signaling would lead to improved neurological functions after cerebral ischemia 
(Xing et al., 2008). 
However, the suggested signaling processes in the previous studies are relevant only for 
later phases in the progression of stroke. In contrast, this study focused on the role of EphB2 
especially during the first hours after cerebral ischemia. Interestingly, analysis of the phos-
phorylation of EphB2 revealed that EphB2 is activated already after 6 h of reperfusion in the 
ischemic hemisphere of Ephb2+/+ mice. In addition to EphB2, the phosphorylation of 38 other 
RTKs, including Eph receptors, was analyzed. Though it was shown previously that the 
RTKs ErbB4 (Guan et al., 2015), MSPR (Suzuki et al., 2008), PDGFR alpha and beta (Ma 
et al., 2011; Renner et al., 2003), TrkA and TrkC (Chung et al., 2017; Lee et al., 1998) as 
well as VEGFR (Greenberg and Jin, 2013) are involved in the progression of brain injury, 
this is the first study to show that the phosphorylation of these RTKs is increased already in 
the first hours after cerebral ischemia. Further, EphB4 and EphB6 showed increased phos-
phorylation upon cerebral ischemia indicating that additional members of the EphB/ephrin-
B system might be involved in the early phase upon stroke. In contrast, the phosphorylation 
level of EphA2 is not increased though it was shown previously in Epha2-/- mice that EphA2 
contributes to neuronal cell death and BBB damage during stroke (Thundyil et al., 2013).  
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The result showing that infarct volumes were reduced after 12 h of MCAo in Ephb2-deficient 
mice and the increased phosphorylation of EphB2 6 h after MCAo suggested that EphB2 
influences the progression of stroke in the early phase upon cerebral I/R injury. 
 
5.2 BBB function and vascular phenotype in the brain are not altered in 
Ephb2-deficient mice 
Alterations in the cerebrovascular anatomy due to the lack of EphB2 could compensate for 
the disturbed blood flow during the MCAo or the subsequent reperfusion thereby influencing 
the progression of stroke. So far, no studies were available regarding the cerebrovascular 
anatomy, capillary density, and pericyte coverage of brain vessels in Ephb2-deficient mice, 
though EphB2 and EphB2 ligands play a crucial role during vasculogenesis (Adams et al., 
1999; Gerety and Anderson, 2002). However, this study revealed that the reduction in re-
gional cerebral rCBF during MCAo was not altered in Ephb2-deficient mice. Further, cere-
brovascular anatomy, capillary density, and pericyte coverage of brain vessels were com-
parable in Ephb2+/+ and Ephb2-/- mice indicating that the attenuated progression of stroke 
cannot be explained by an altered cerebrovascular system. The expression of gene-prod-
ucts in contralateral (normoxic) hemispheres of mice subjected to MCAo was analyzed to 
investigate if Ephb2-deficient mice had an altered expression pattern of gene products re-
lated to the function of endothelial cells. Gene sets associated with the regulation of activa-
tion of endothelial cells were comparable between Ephb2+/+ and Ephb2-/- mice. In conclu-
sion, the decrease in the progression of stroke in Ephb2-deficient mice cannot be ascribed 
to an altered cerebrovascular anatomy or changes in transcripts related to the activation of 
endothelial cells.  
A major complication in the clinical therapy of stroke is the treatment of the developing vas-
ogenic edema which arises upon cerebral ischemia. Vasogenic edema evolves from an 
increase in the permeability of the BBB thereby allowing extravasation of fluid into the brain 
parenchyma (Gelderblom et al., 2009). Though Ephb2-deficient mice did not show altera-
tions in the cerebrovascular anatomy, the function of endothelial cells in the BBB might be 
influenced by the lack of EphB2-mediated signaling. Important regulators of the stability of 
the BBB are tight junctional proteins which connect the endothelial cells in the BBB. Subtle 
endothelial cytoskeletal reorganization is already detectable almost immediately after I/R 
injury leading to slight increases in BBB permeability (Shi et al., 2016). Interestingly, the 
EphB/ephrin-B system was shown to affect endothelial permeability. Ephrin-B-mediated re-
verse signaling in endothelial cells, which can be induced by EphB2, influences the junc-
tional integrity and pro-inflammatory differentiation of endothelial cells (Liu et al., 2014). Fur-
ther, mice deficient for Epha2 showed decreased BBB permeability upon MCAo and re-
duced infarct sizes to a similar extent as Ephb2-deficient mice in this study (Thundyil et al., 
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2013). These aforementioned data suggested that BBB permeability could evolve to a 
lesser extent when EphB2-mediated signaling processes are absent. In this study, BBB 
hyperpermeability was analyzed by quantification of Evans Blue extravasation but was not 
different between Ephb2+/+ and Ephb2-/- mice. As it was shown previously that EphB2 lig-
ands interact with endothelial junctional proteins (Liu et al., 2014), next it was investigated 
if endothelial cytoskeletal reorganization might be diminished in the absence of EphB2. 
However, this study showed that the disassembly in endothelial tight junctions upon stroke 
was similar in both genotypes. Finally, edema formation was assessed by MRI, which al-
lowed to distinguish vasogenic and cytotoxic edema formation (Barber et al., 2005; Rumpel 
et al., 1998). As mentioned before, vasogenic edema formation requires increased vascular 
permeability. In line with the previous data obtained from histological analyses in this study, 
vasogenic edema was smaller in Ephb2-deficient mice after 24 h of reperfusion. Though 
vasogenic edema formation can be monitored by T2-relaxometry already 90 min after I/R 
injury (Barber et al., 2005), there was no difference in vasogenic edema volume after 6 h of 
reperfusion between the two genotypes. The results from this study suggest that the loss of 
EphB2 and the absence of EphB2-mediated signaling does not affect the vascular compo-
nent, such as endothelial permeability, during the progression of stroke. A possible expla-
nation could be that EphB3 compensates for the loss of EphB2. Adams and colleagues 
showed before that mice deficient for either Ephb2 or Ephb3 do not exhibit vascular defects 
while in Ephb2/Ephb3 double mutants the embryonic vascular development was impaired 
(Adams et al., 1999).  
In contrast to vasogenic edema, cytotoxic edema evolves from cytotoxic cell swelling which 
is independent of additional water influx into the brain parenchyma but a consequence of 
ion pump failure (Brouns and De Deyn, 2009). Unlike vasogenic edema, cytotoxic cell swell-
ing differed already after 6 h of reperfusion in the infarction core between the two genotypes 
in this study. These data suggest that the lack of EphB2-mediated signaling attenuates the 
progression of stroke rather by limiting cytotoxic cell swelling during the first hours after 
stroke than by affecting the stability of the BBB. Consequently, vasogenic edema formation 
is indirectly attenuated in Ephb2-deficient mice. Cytotoxic cell swelling is driven by the de-
pletion of ATP due to focal hypoperfusion and arises prior to vasogenic edema (Yan et al., 
2015). Subsequently, the function of ion pumps fails and leads to a dysbalance in ion ho-
meostasis. The increased ion influx is followed by water inflow thereby inducing cell swelling 
which can trigger cell death (Dirnagl et al., 1999). Astrocytes play a crucial role in the clear-
ance of extracellular potassium ions and glutamate and are therefore susceptible to cell 
swelling caused by ion dysbalance. In addition to astrocytes, neuronal cells undergo swell-
ing not only due to ion dysbalance but also because of hyperactivation of glutamate recep-
tors, such as NMDA receptors (Choi and Rothman, 1990; Rossi et al., 2007; Wang and 
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Parpura, 2016). Though the main part of cytotoxic edema formation, which evolved to a 
lesser extent in Ephb2-deficient mice upon I/R injury (this study), supposedly is caused by 
astrocytic cell swelling, neurons are more susceptible to ischemia-induced cell swelling and 
death (Liang et al., 2007). 
 
5.3 EphB2 promotes NMDA-triggered Ca2+ influx into mitochondria 
So far, many studies have focused on the role of the neuronal NMDA receptor-mediated 
excitotoxicity as it represents one of the most relevant signaling mechanisms triggering cell 
death induced by ion dysbalance (Kalia et al., 2008a; Lai et al., 2011; Martin and Wang, 
2010). The NMDA receptor is an important receptor in excitatory synaptic transmission by 
increasing Ca2+ influx into the postsynapse upon binding of glutamate and glycine. Many 
clinical trials targeting NMDA receptors during stroke failed, among others due to severe 
side effects as the NMDA receptor is of pivotal physiological importance (Kalia et al., 2008a; 
Lai et al., 2014).  
Indeed, this study showed that NMDA-induced elevation of mitochondrial Ca2+ levels and 
membrane depolarization, which precede neuronal excitotoxicity, are reduced in Ephb2-
deficient neurons. EphB2 was shown to influence NMDA receptor-mediated Ca2+ influx be-
fore (Takasu et al., 2002). A disturbed NMDA receptor-mediated signaling in Ephb2-defi-
cient mice could lead to reduced neuronal cytotoxic cell swelling and subsequently to atten-
uation in the progression of stroke. The connection of disturbed NMDA receptor signaling 
and reduced infarct volume was already shown before in other studies. In mice and respec-
tive neuronal cultures treated with pertussis toxin or genetically altered mice, which are 
haploinsufficient for the NMDA receptor subunit NR2B, NMDA receptor signaling is impaired 
and brain damage is reduced (Tang et al., 2015; Tang et al., 2018). In the study presented 
here, basal mitochondrial Ca2+ levels differed between Ephb2+/+ and Ephb2-/- neurons. This 
suggests that mitochondrial Ca2+ uptake is already reduced when extracellular Ca2+ influx 
depends on NMDA receptors without functional EphB2. In contrast to mitochondrial Ca2+ 
levels, changes in cytoplasmic Ca2+ levels in NMDA-stimulated neurons were surprisingly 
not differently regulated in Ephb2-/- neurons as compared to Ephb2+/+ neurons. Cytoplasmic 
and mitochondrial Ca2+ responses upon NMDA stimulation usually show similar time 
courses (Peng and Greenamyre, 1998; Stanika et al., 2009b) or both parameters are altered 
as studies in genetically modified neurons have shown (Martorell-Riera et al., 2014; Qiu et 
al., 2013). However, Takasu et al. also observed that changes of cytoplasmic Ca2+ levels 
upon stimulation with glutamate occur also independently of EphB2: Overexpression of 
wildtype EphB2 or a construct of EphB2 lacking the cytoplasmic kinase domain in hippo-
campal neurons does not lead to different changes in cytoplasmic Ca2+ levels upon stimu-
lation with glutamate. On the contrary, treatment with recombinant ephrin-B2 prior to 
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glutamate stimulation, which activates EphB2, increases cytoplasmic Ca2+ but only in neu-
rons transfected with the wildtype EphB2 construct (Takasu et al., 2002). These data sug-
gest that the mitochondria in Ephb2-/- neurons have a decreased NMDA receptor-dependent 
Ca2+ load. On the contrary, mitochondrial Ca2+ levels which are not solely regulated by 
NMDA receptor and cytoplasmic Ca2+ are similar in comparison to Ephb2+/+ neurons. 
Though mitochondria play a crucial role in buffering changes in Ca2+ levels upon stimulation 
by their capacity to take Ca2+ up, they are not considered as vast Ca2+ stores. Intracellular 
Ca2+ levels are tightly regulated at many sites of action. The majority is stored in the endo-
plasmic reticulum or is bound to cytosolic proteins. Typically, the concentration of free cyto-
solic Ca2+ is maintained at approximately 100 nM. During basal conditions, Ca2+ levels in 
mitochondria are usually also maintained at a constant level. Mitochondrial Ca2+ uptake is 
mediated by a Ca2+-sensitive uniporter allowing a net influx of Ca2+ when cytoplasmic Ca2+ 
is elevated. Ca2+ release from mitochondria is mainly regulated by a Na+/Ca2+ exchanger 
during recovery after stimulation (Duchen, 2000; Pivovarova and Andrews, 2010). In con-
clusion, a decreased mitochondrial Ca2+ load in Ephb2-/- neurons could compensate in-
creases in cytoplasmic Ca2+ upon NMDA stimulation which would explain why cytoplasmic 
Ca2+ levels were not altered while the mitochondrial responses were still different.  
Mitochondrial dysfunction including mitochondrial Ca2+ overload and mitochondrial mem-
brane depolarization is a hallmark of NMDA receptor-induced neuronal cell death (Bading, 
2017). Though NMDA receptor-mediated mitochondrial Ca2+ load was decreased in the ab-
sence of EphB2, it was not clear if the differences in mitochondrial Ca2+ levels would lead to 
differences which might result in an impaired mitochondrial function. This study showed that 
NMDA-evoked changes in mitochondrial membrane potential were less increased in Ephb2-
deficient neurons compared to Ephb2+/+ neurons at NMDA concentration which can lead to 
excitotoxicity. Ca2+ influx into mitochondria decreases the electrochemical gradient leading 
to reduced ATP synthesis and accumulation of intramitochondrial Ca2+(Pivovarova and 
Andrews, 2010). Further, pro-apoptotic proteins are released, the protease calpain is acti-
vated and ROS production is increased (Pivovarova and Andrews, 2010). Together, these 
processes induce rapid necrotic, caspase-independent as well as caspase-dependent cell 
death (Niizuma et al., 2010; Zhan et al., 2001). In conclusion, the reduction in NMDA recep-
tor-mediated Ca2+ load of mitochondria and subsequent membrane depolarization in Ephb2-
deficient neurons suggests a dysfunction of NMDA receptor-mediated mitochondrial pro-
cesses in the absence of EphB2. Against this background, it is tempting to speculate that 
the reduction in neuronal cell death upon cerebral ischemia in Ephb2-deficient mice is 
caused by a dysfunctional mitochondrial Ca2+ load of the NMDA receptor.  
In addition to the observed altered mitochondrial Ca2+ load, an attenuation of NMDA recep-
tor-mediated cell death induction in Ephb2-deficient neurons is supported by results 
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obtained from other studies. As mentioned before, the function of the NMDA receptor is 
influenced by several different factors. EphB2 has intensively been studied for its interaction 
with and functional impact on the glutamate receptor NMDA receptor. In addition to co-
activators, the mechanism of action and subsequent downstream signaling of the NMDA 
receptor is influenced by its subunit composition as well as the localization of the receptor 
complex (Lai et al., 2011; Liu et al., 2007). Further, the overall development of excitatory 
synapses depends on the recruitment of NMDA receptor which is essential for synaptic 
plasticity (Cull-Candy et al., 2001). The interaction of the extracellular domains of EphB2 
and the NR1 subunit of the NMDA receptor enables EphB2 to influence the localization and 
function of the NMDA receptor. Interestingly, extrasynaptic NMDA receptors are mainly 
composed of NR2B subunits and Nolt and colleagues showed that EphB2 is involved in 
directing NR2B to its designated target (Nolt et al., 2011). Activation of extrasynaptic NMDA 
receptors induces mitochondrial dysfunction and neuronal cell death, while activation of 
synaptic NMDA receptors rather drives neuroprotective pathways. It is suggested that ex-
trasynaptic NMDA receptors are closer located to mitochondria than synaptic NMDA recep-
tors. Additionally, the postsynaptic protein complexes could shield the mitochondria from 
NMDA receptor. Consequently, extrasynaptic mitochondria would be more directly exposed 
to calcium ions entering the cell through the NMDA receptor (Bading, 2017). The function 
of NMDA receptors is modified by EphB2 and in light of these facts, one could speculate 
that NMDA receptors in Ephb2-deficient neurons might be functionally impaired and incor-
rectly located. Both could lead to reduced Ca2+ influx through extrasynaptic NMDA receptors 
and a subsequent reduced Ca2+ load of mitochondria during cerebral ischemia resulting in 
reduced cell death induction. 
 
5.4 Synaptic activity is altered in Ephb2-deficient neurons  
Though the main function of both, synaptic and extrasynaptic NMDA receptors is the regu-
lation of Ca2+ influx into the neuron, the subsequent signaling pathways differ. While the 
experiments so far involved activation of all forms of the NMDA receptor, the next experi-
ments aimed mainly on the function of synaptic NMDA receptors. As mentioned before, 
synaptic NMDA receptors are involved in pro-survival pathways suggesting that alterations 
in this function could also influence neuronal survival. Synaptic activity was induced by the 
GABAa receptor antagonist gabazine. GABAergic neurons inhibit excitotoxic neurons 
thereby modulating synaptic activity in the CNS (Purves and Williams, 2001). Application of 
the GABAa receptor antagonist Bicuculline reverses the GABAergic inhibitory effect and 
leads to rapid AP spikes, called burst (AP burst). This enables Ca2+ influx through synaptic 
NMDA receptors which in turn triggers calcium-dependent activation of gene expression 
programs. In particular, the neuroprotective transcription factor CREB is activated upon 
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nuclear calcium signaling (Hardingham et al., 2001; Papadia et al., 2005). In this study, 
mitochondrial Ca2+ levels were not altered in Ephb2-deficient neurons during AP burst in-
duced by the GABAa receptor antagonist gabazine. As this stimulation activates mainly 
synaptic NMDA receptors, this result is in line with the previous claim that activation of syn-
aptic NMDA receptors alone is not involved in mitochondrial dysfunction (Zhou et al., 2013). 
Further, Ephb2-deficient neurons showed reduced elevated cytoplasmic Ca2+ levels during 
AP burst indicating reduced synaptic activity. This is in line with experiments of Grunwald 
and Henderson who demonstrated that Ephb2-deficient mice have defects in synaptic plas-
ticity as the protein-synthesis required for long-term potentiation was defective (Grunwald 
et al., 2001; Henderson et al., 2001). Additionally, in this study gene sets associated with 
pathways involved in synaptic function and NMDA receptors were less activated in Ephb2-
deficient contralateral (normoxic) brain hemispheres when compared to Ephb2+/+ indicating 
impaired synaptic function in Ephb2-deficient mice. NMDA receptor-dependent synaptic 
dysfunction can be reversed by EphB2 overexpression in a murine Alzheimer model (Cissé 
et al., 2011) implying the diverse aspects of EphB2- and NMDA receptor-mediated signal-
ing. This result seems to be contradictory to the previous results, which suggested that im-
paired NMDA receptor signaling is beneficial and would reduce excitotoxicity. The reduced 
synaptic activity would subsequently lead to a reduced induction of expression of neuropro-
tective gene programs. However, the dynamics of activation of either synaptic or extrasyn-
aptic NMDA receptor or simultaneous activation of both kinds of NMDA receptor are still 
under debate. Zhou and colleagues suggested that the dose of NMDA applied to neurons 
also influences whether extrasynaptic or synaptic NMDA receptor are activated. They im-
plied that high doses of NMDA, which would be equivalent to the massive glutamate con-
centrations present in the ischemic brain, preferably activate extrasynaptic NMDA receptors 
thereby triggering excitotoxic cell death. On the other hand, low doses would activate pro-
survival gene programs through synaptic NMDA receptor. Importantly, though the toxic ef-
fect seems to be primarily regulated by activation of extrasynaptic NMDA receptors, activa-
tion of extrasynaptic NMDA receptors alone leads only to changes in Ca2+ transients but it 
does not induce detrimental dysregulation of Ca2+ homeostasis or cell death. Mitochondrial 
dysfunction and cell death induction seem to be dependent on the simultaneous activation 
of synaptic and extrasynaptic NMDA receptors (Hardingham et al., 2002; Zhou et al., 2013). 
Though synaptic responses are reduced in Ephb2-deficient neurons, both, synaptic and 
extrasynaptic NMDA receptors can still be activated. Therefore, NMDA receptor-mediated 
neuronal cell death induction is still possible in Ephb2-deficient neurons but could be atten-
uated.  
Additional mechanistic insights might be gained from the analysis of a solely synaptic-driven 
NMDA receptor-protective function in Ephb2-deficient neurons. Lau and colleagues showed 
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that the neuroprotective mechanism of BDNF acts via initiating synaptic NMDA receptor-
driven expression of inhibin β-A which subsequently reduces neurotoxic extrasynaptic 
NMDA receptor signaling. As Ephb2-deficient neurons show impairments in both, extrasyn-
aptic and synaptic NMDA receptor signaling, the decrease in extrasynaptic NMDA receptor-
mediated Ca2+ influx upon BDNF application should be reduced in Ephb2-deficient neurons 
when compared to Ephb2+/+ neurons (Lau et al., 2015).    
 
5.5 Excitotoxic neuronal cell death induction in vitro differs from cerebral 
ischemia-induced neuronal degeneration in vivo 
The aforementioned results suggested that Ephb2-deficient neurons are less susceptible to 
NMDA receptor-mediated cell death induction. Therefore, the next experiments in this study 
focused on the detection of cell death levels after stimulation of the NMDA receptor or by 
exposure to OGD. However, in the chosen experimental setup, neither NMDA-stimulated 
nor OGD-challenged Ephb2-deficient neurons showed detectable differences in the fraction 
of dead cells as compared to Ephb2+/+ neurons. It is important to take into consideration that 
the experimental setup used in the cell death assay was not comparable with the conditions 
used for the detection of mitochondrial Ca2+ levels upon NMDA stimulation. Mitochondrial 
Ca2+ levels were decreased in Ephb2-deficient neurons when the Ca2+ influx solely de-
pended on the NMDA receptor but not if other Ca2+ channels were still active. The experi-
mental setup for the detection of the fraction of dead cells, however, did not include inhibition 
of other voltage-dependent Ca2+ channels, AMPA receptors, or voltage-dependent sodium 
channels. Further, the differences in mitochondrial Ca2+ levels were detected almost imme-
diately upon stimulation of the NMDA receptor while the detection of dead cells was per-
formed more than 16 h later. During this time, calcium and glutamate released from dying 
neurons could potentiate excitotoxicity and activate further signaling processes. Therefore, 
the addition of NMDA to cultured neurons without inhibiting other Ca2+ channels is not com-
parable to the situation which led to differences in mitochondrial Ca2+ levels and mitochon-
drial membrane depolarization. Though neuronal degeneration was attenuated in Ephb2-
deficient mice, it is likely that function and signaling processes of cultured neurons do not 
mirror the more complex situation in vivo which showed decreased neuronal cell death. 
Activation of the NMDA receptor during OGD is considered to trigger the main part of neu-
ronal cell death induction. However, Aarts and colleagues demonstrated an NMDA-inde-
pendent cell death mechanism during prolonged OGD. Cell death induction in cortical neu-
rons subjected to 1 h of OGD followed by approximately 24 h of re-oxygenation was almost 
completely inhibited when the glutamate receptor (NMDA receptors, AMPA receptors, and 
kainate receptors) antagonists were applied. In the presence of a specific NMDA receptor 
antagonist, cell death levels were greatly reduced after 1 h of OGD. After 1.5 h, the levels 
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of cell death were still reduced when an NMDA receptor antagonist was present but to reach 
a similar reduction as after 1 h, AMPA and kainite receptors had to be also blocked. When 
OGD was extended to 2 h, the antagonists failed to reduce the fraction of cell death (Aarts 
et al., 2003). Hence, the chosen setup for cell death induction by OGD in this study (3 h) 
did not solely aim at NMDA receptor-mediated cell death induction. Therefore, future exper-
iments should be conducted by specifically targeting the NMDA receptor-mediated cell 
death signaling process and should further rule out that released molecules of dying neu-
rons induce further NMDA receptor-independent cell death processes.      
 
5.6 Involvement of EphB2 ligands in brain injury models  
In addition to the altered function of NMDA receptors at the post-synapse, further EphB2-
dependent signaling mechanisms might be altered in Ephb2-deficient mice. Though many 
studies have been dealing with the questions about localization and function of members of 
the EphB/ephrin-B family, many questions remain open. The expression pattern of EphB 
receptors and ephrin-B ligands in the CNS is diverse and complex (Hruska and Dalva, 2012; 
Kania and Klein, 2016; Klein, 2009; Pasquale, 2008). Further, the interaction of EphB and 
ephrin-B induces signaling processes in both cells, the EphB and the ephrin-B-expressing 
cell. Immunofluorescence staining techniques applied on cryo-sections of Ephb2+/+ and 
Ephb2-/- mice subjected to cerebral ischemia showed similar expression patterns of EphB2 
ligands (visualized after 6 h of reperfusion prior to any substantial loss of cells) as well as 
similar loss of the ephrin-B-specific signal outside of vessel-like structures after 24 h of 
reperfusion. Importantly, the association of EphB2 with the NMDA receptor is driven by in-
teraction with EphB2 ligands, such as ephrin-B1 and -B2. Further, it was shown that the 
EphB2-mediated modulation of NMDA receptor function requires activation of EphB2 by 
ephrin-B (Dalva et al., 2000; Takasu et al., 2002). Post-synaptic EphB2 could be activated 
by pre-synaptic ephrin-B1/2/3 during cerebral ischemia. However, activation of EphB2 can 
also occur by ephrin-B present on non-neuronal cells. For example, astrocytes are in phys-
ical contact with neurons and are involved in several neuronal functions. They contribute to 
ion homeostasis by potassium or glutamate release (Bellot-Saez et al., 2017). Further, they 
participate in neuronal development and have even been shown to regulate memory for-
mation and synaptic plasticity (Ota et al., 2013; Pál, 2015; Pirttimaki et al., 2017). Astrocytic 
ephrin-B1 modulates remodeling of synapses upon traumatic brain injury as shown by the 
acceleration of the recovery of glutamatergic synapses in astrocytic-specific ablation of 
ephrin-B1 (Nikolakopoulou et al., 2016). In contrast to the results in this study, which showed 
reduced cell death in the absence of EphB2-mediated signaling, activation of neuronal 
EphB1-mediated signaling triggers neuroprotective pathways via interaction with astrocytic 
ephrin-B1 (Tyzack et al., 2017). Further, Bundesen and colleagues suggested that 
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astrocytic ephrin-B2 regulates glial scar formation by interaction with EphB2 on fibroblasts 
upon spinal cord injury (Bundesen et al., 2003) indicating that further steps during the pro-
gression of stroke could additionally be influenced in Ephb2-deficient mice. Analysis of mice 
with a CNS cell-specific deletion of Ephrinb2 showed decreased infarct and edema volume 
upon MCAo followed by 24 h of reperfusion (unpublished data) indicating that ephrin-B2 is 
also important during the acute phase of stroke. Further, astrocytes derived from Ephb2-
deficient mice showed reduced pro-inflammatory activation upon stimulation with recombi-
nant EphB2 protein in cell culture experiments. Interestingly, stimulation of WT astrocytes 
with EphB2 promotes translocation of nuclear factor kappa B (NF-kB) into the nucleus (see 
PhD thesis Laura-Inés Böhler). The lack of EphB2 could additionally affect the inflammatory 
response of the resident cells in the brain, such as astrocytes and microglia, by diminishing 
EphB2-induced ephrin-B reverse signaling thereby further attenuating brain tissue damage.  
 
5.7 Proposed model of EphB2-dependent NMDA receptor-mediated exci-
totoxicity  
Taken together, this study showed that EphB2 contributes to the formation of cytotoxic 
edema during the first hours after cerebral stroke which is independent of BBB breakdown. 
Further, Ephb2-deficient neurons reacted differently upon NMDA receptor stimulation as the 
mitochondrial Ca2+ levels and membrane depolarization were decreased. Importantly, these 
parameters are involved in mediating NMDA receptor-induced excitotoxicity. Based on 
these results and previous findings it is proposed that EphB2 is involved in neuronal cell 
death induction after hyperactivation of NMDA receptor during cerebral ischemia. In the 
absence of EphB2, detrimental Ca2+ influx through (extra-)synaptic NMDA receptors is im-
paired  
The extracellular domain of EphB2 interacts with the NMDA receptor subunit NR1 upon 
interaction with ephrin-B (shown by Grunwald et al. 2001; Takasu et al. 2002)). The NMDA 
receptor is stimulated by excessive glutamate during cerebral ischemia (Dingledine et al., 
1999). Src family kinases are recruited by the intracellular domain of EphB2 and interact 
with the cytoplasmic tail of the NMDA receptor and induce phosphorylation of the NR2B 
subunit at tyrosine residue 1472 (Antion et al., 2010; Brückner and Klein, 1998; Takasu et 
al., 2002). Ca2+ influx through the NMDA receptor increases and triggers signaling cascades 
promoting neuronal cell death which would be attenuated in Ephb2-deficient neurons.  
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Figure 30: Scheme depicting the proposed mechanism of EphB2-mediated neuronal excitotoxicity. 
The membrane-bound RTK EphB2 is activated by a membrane-bound ephrin-B ligand (event 1). 
Next, the extracellular domain of EphB2 interacts with the NR1 subunit of the NMDA receptor 
(NMDAR) (event 2,) which is overstimulated during cerebral ischemia by excessive glutamate (event 
3). The intracellular domain of EphB2 recruits members of the Src family kinases (event 4), which 
subsequently induce phosphorylation (℗) of the NMDA receptor subunit NR2B (event 5), and Ca2+ 
influx through the NMDA receptor increases. Then, nNOS is activated (event 6) and DAPK1 recruited 
inducing further signaling events (event 7). The increase in intracellular Ca2+ is buffered by mitochon-
dria as they take up Ca2+ (event 8). This leads to mitochondrial membrane depolarization, activation 
of pro-apoptotic factors and mitochondrial dysfunction and finally cumulates in cell death induction 
(event 9). In the absence of EphB2, glutamate-induced NMDA receptor signaling during cerebral 
ischemia is impaired and cell death induction is decreased (results this study). Glutamate is repre-
sented by black dots. 
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Ca2+ influx through the NMDA receptor leads to activation of CaM which in turn activates 
neuronal nitric oxide synthase (nNOS). Activation of nNOS leads to ROS formation. Neu-
ronal NOS is coupled via the post-synaptic density protein 95 (PSD-95) to the NMDA re-
ceptor and disruption of the PSD-95-nNOS complex leads to decreased infarct sizes in mice 
subjected to MCAo (Zhou et al., 2010). Another consequence of NMDA receptor activation 
during ischemia is the recruitment of DAPK1 which further was shown to promote neuronal 
excitotoxicity (Tu et al., 2010). NMDA receptor signaling further includes the activation of 
MAP kinases, such as the c-Jun N-terminal kinase (JNK). Inhibition of JNKs is also neuro-
protective during cerebral ischemia (Borsello et al., 2003; Esneault et al., 2008). In addition 
to the interruption of the NMDA receptor signaling processes, the localization, and compo-
sition of NMDA receptors in Ephb2-deficient neurons could be altered (Nolt et al., 2011) and 
would make these neurons less susceptible to NMDA receptor-mediated cell death induc-
tion. Figure 30 illustrates the proposed mechanism. A similar mechanism was already sug-
gested by Yuferov and colleagues who showed that high expression of EphB2 correlates 
with increased cognitive impairments in HIV-positive patients (Yuferov et al., 2013).  
It remains a challenging question how NMDA receptor-mediated cell death induction during 
stroke can be interrupted without interfering with the physiological requirement of proper 
NMDA receptor function in human patients. This study suggests that detrimental Ca2+ influx 
through extrasynaptic NMDA receptor is modulated by EphB2. Targeting EphB2 in this con-
text could reduce this Ca2+ influx. In this way, the function of the NMDA receptor would be 
partially maintained but neuronal cell death induction could be reduced.  
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6 Appendix 
 
Table 8 Transcriptome analysis of Ephb2+/+ mice after stroke. Ephb2+/+ mice were subjected to 
60 min middle cerebral artery occlusion (MCAo) followed by 48 h of reperfusion. DNA microarray and 
gene set enrichment analysis of the ipsi- and contralateral hemispheres showed differentially regu-
lated pathways (obtained from KEGG database). N=3. Only pathways showing NES >1.5 or <-1.5, 
p<0.05 and FDR<0.1 were included. NES=normalized enrichment score, FDR=false discovery rate 
Pathway NES p value FDR 
Staphylococcus aureus infection 2.49 <0.001 <0.001 
Leishmaniasis 2.49 <0.001 <0.001 
Complement and coagulation cascades 2.46 <0.001 <0.001 
ECM-receptor interaction 2.46 <0.001 <0.001 
Focal adhesion 2.41 <0.001 <0.001 
Osteoclast differentiation 2.38 <0.001 <0.001 
Cytokine-cytokine receptor interaction 2.37 <0.001 <0.001 
Phagosome 2.37 <0.001 <0.001 
Toxoplasmosis 2.35 <0.001 <0.001 
Pertussis 2.34 <0.001 <0.001 
Tuberculosis 2.33 <0.001 <0.001 
Leukocyte transendothelial migration 2.31 <0.001 <0.001 
Proteoglycans in cancer 2.28 <0.001 <0.001 
Hematopoietic cell lineage 2.27 <0.001 <0.001 
Chagas disease (American trypanosomiasis) 2.27 <0.001 <0.001 
B cell receptor signaling pathway 2.25 <0.001 <0.001 
Toll-like receptor signaling pathway 2.23 <0.001 <0.001 
Influenza A 2.23 <0.001 <0.001 
Measles 2.22 <0.001 <0.001 
Malaria 2.20 <0.001 <0.001 
Pancreatic cancer 2.19 <0.001 <0.001 
TNF signaling pathway 2.19 <0.001 <0.001 
Jak-STAT signaling pathway 2.19 <0.001 <0.001 
NF-kappa B signaling pathway 2.19 <0.001 <0.001 
Rheumatoid arthritis 2.18 <0.001 <0.001 
Apoptosis 2.17 <0.001 <0.001 
Antigen processing and presentation 2.17 <0.001 <0.001 
Inflammatory bowel disease (IBD) 2.17 <0.001 <0.001 
Hepatitis B 2.16 <0.001 <0.001 
Herpes simplex infection 2.12 <0.001 <0.001 
Amoebiasis 2.11 <0.001 <0.001 
Salmonella infection 2.11 <0.001 <0.001 
Small cell lung cancer 2.11 <0.001 <0.001 
HIF-1 signaling pathway 2.11 <0.001 <0.001 
PI3K-Akt signaling pathway 2.09 <0.001 <0.001 
Transcriptional misregulation in cancer 2.09 <0.001 <0.001 
p53 signaling pathway 2.06 <0.001 <0.001 
Cell cycle 2.06 <0.001 <0.001 
Lysosome 2.06 <0.001 <0.001 
HTLV-I infection 2.05 <0.001 <0.001 
Epstein-Barr virus infection 2.05 <0.001 <0.001 
Natural killer cell mediated cytotoxicity 2.05 <0.001 <0.001 
Legionellosis 2.04 <0.001 <0.001 
Viral myocarditis 2.03 <0.001 <0.001 
Asthma 2.00 <0.001 <0.001 
Chemokine signaling pathway 1.98 <0.001 <0.001 
Graft-versus-host disease 1.98 <0.001 <0.001 
Systemic lupus erythematosus 1.97 <0.001 <0.001 
Bacterial invasion of epithelial cells 1.97 <0.001 <0.001 
Fc gamma R-mediated phagocytosis 1.97 <0.001 <0.001 
DNA replication 1.96 <0.001 <0.001 
Viral carcinogenesis 1.95 <0.001 <0.001 
Mineral absorption 1.94 <0.001 <0.001 
MicroRNAs in cancer 1.94 <0.001 <0.001 
Chronic myeloid leukemia 1.94 0.002 <0.001 
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Proteasome 1.91 <0.001 0.001 
Fc epsilon RI signaling pathway 1.91 <0.001 0.001 
Hepatitis C 1.90 <0.001 0.001 
Regulation of actin cytoskeleton 1.90 <0.001 0.001 
Protein processing in endoplasmic reticulum 1.88 <0.001 0.001 
Cell adhesion molecules (CAMs) 1.86 <0.001 0.001 
Intestinal immune network for IgA production 1.85 <0.001 0.001 
Allograft rejection 1.85 <0.001 0.002 
Prion diseases 1.84 <0.001 0.002 
Platelet activation 1.83 <0.001 0.002 
Acute myeloid leukemia 1.82 0.002 0.002 
NOD-like receptor signaling pathway 1.79 <0.001 0.003 
Prostate cancer 1.79 <0.001 0.003 
Sphingolipid signaling pathway 1.79 <0.001 0.003 
Pathways in cancer 1.79 <0.001 0.003 
TGF-beta signaling pathway 1.78 0.002 0.004 
Autoimmune thyroid disease 1.75 <0.001 0.006 
Cytosolic DNA-sensing pathway 1.75 <0.001 0.006 
Colorectal cancer 1.74 0.002 0.006 
T cell receptor signaling pathway 1.74 0.002 0.006 
VEGF signaling pathway 1.74 0.002 0.006 
Type I diabetes mellitus 1.74 0.004 0.006 
Glioma 1.74 <0.001 0.007 
Steroid biosynthesis 1.73 0.015 0.007 
Glycosaminoglycan degradation 1.72 0.008 0.008 
Spliceosome 1.70 <0.001 0.009 
MAPK signaling pathway 1.67 <0.001 0.012 
Porphyrin and chlorophyll metabolism 1.67 0.014 0.012 
Adherens junction 1.67 0.002 0.013 
Bladder cancer 1.66 0.005 0.014 
Renal cell carcinoma 1.65 0.007 0.015 
FoxO signaling pathway 1.64 0.002 0.016 
Non-alcoholic fatty liver disease (NAFLD) 1.61 0.002 0.021 
Melanoma 1.61 0.006 0.021 
Protein digestion and absorption 1.60 0.011 0.022 
RIG-I-like receptor signaling pathway 1.59 0.003 0.024 
Pentose and glucuronate interconversions 1.58 0.024 0.028 
Hypertrophic cardiomyopathy (HCM) 1.55 0.008 0.034 
Adipocytokine signaling pathway 1.55 0.015 0.035 
Prolactin signaling pathway 1.54 0.013 0.038 
Endocytosis 1.53 <0.001 0.039 
One carbon pool by folate 1.53 0.039 0.038 
Primary bile acid biosynthesis 1.50 0.071 0.049 
Hippo signaling pathway 1.50 0.005 0.050 
Rap1 signaling pathway 1.50 0.005 0.050 
Dopaminergic synapse -1.50 0.006 0.081 
Amphetamine addiction -1.59 0.005 0.036 
Glycosaminoglycan biosynthesis - HS/Hep -1.63 0.006 0.028 
Neuroactive ligand-receptor interaction -1.67 <0.001 0.019 
Calcium signaling pathway -1.69 <0.001 0.018 
GABAergic synapse -1.71 <0.001 0.016 
Circadian entrainment -1.73 <0.001 0.014 
Parkinson's disease -1.73 <0.001 0.015 
Retrograde endocannabinoid signaling -1.76 <0.001 0.013 
Glutamatergic synapse -1.83 <0.001 0.006 
Cocaine addiction -1.86 <0.001 0.004 
Morphine addiction -1.94 <0.001 0.002 
Nicotine addiction -2.24 <0.001 <0.001 
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Table 9: Comparison of transcriptomes of Ephb2+/+ and Ephb2-/- mice upon stroke. Mice were sub-
jected to 60 min middle cerebral artery occlusion (MCAo) followed by 48 h of reperfusion. DNA mi-
croarray and gene set enrichment analysis of the ipsilateral hemispheres showed differentially regu-
lated pathways (obtained from KEGG database). N=3. Only pathways showing NES >1.5 or <-1.5, 
p<0.05 and FDR<0.1 were included. NES=normalized enrichment score, FDR=false discovery rate 
Pathway NES p value FDR  
ECM-receptor interaction -2.46 <0.001 <0.001 
Focal adhesion -2.29 <0.001 <0.001 
Small cell lung cancer -2.27 <0.001 <0.001 
Cytokine-cytokine receptor interaction -2.23 <0.001 <0.001 
Toxoplasmosis -2.22 <0.001 <0.001 
NF-kappa B signaling pathway -2.20 <0.001 <0.001 
TNF signaling pathway -2.17 <0.001 <0.001 
Complement and coagulation cascades -2.16 <0.001 <0.001 
Leukocyte transendothelial migration -2.15 <0.001 <0.001 
p53 signaling pathway -2.13 <0.001 <0.001 
Proteoglycans in cancer -2.12 <0.001 <0.001 
Leishmaniasis -2.11 <0.001 <0.001 
HIF-1 signaling pathway -2.08 <0.001 <0.001 
B cell receptor signaling pathway -2.07 <0.001 <0.001 
Osteoclast differentiation -2.07 <0.001 <0.001 
Legionellosis -2.06 <0.001 <0.001 
Staphylococcus aureus infection -2.06 <0.001 <0.001 
Malaria -2.06 <0.001 <0.001 
Pertussis -2.05 <0.001 <0.001 
Antigen processing and presentation -2.00 <0.001 0.001 
Amoebiasis -2.00 <0.001 0.001 
Rheumatoid arthritis -2.00 <0.001 0.001 
Apoptosis -2.00 <0.001 0.001 
Proteasome -1.98 <0.001 0.001 
PI3K-Akt signaling pathway -1.97 <0.001 0.001 
Jak-STAT signaling pathway -1.97 <0.001 0.001 
Toll-like receptor signaling pathway -1.97 <0.001 0.001 
Hematopoietic cell lineage -1.96 <0.001 0.001 
Chagas disease (American trypanosomiasis) -1.94 <0.001 0.001 
Tuberculosis -1.93 <0.001 0.001 
Phagosome -1.93 <0.001 0.001 
Spliceosome -1.92 <0.001 0.001 
Influenza A -1.88 <0.001 0.002 
Epstein-Barr virus infection -1.87 <0.001 0.002 
VEGF signaling pathway -1.87 <0.001 0.002 
Protein processing in endoplasmic reticulum -1.87 <0.001 0.002 
Salmonella infection -1.85 0.002 0.002 
Hepatitis B -1.85 <0.001 0.002 
MicroRNAs in cancer -1.84 <0.001 0.003 
Prostate cancer -1.84 <0.001 0.003 
Chronic myeloid leukemia -1.82 <0.001 0.003 
FoxO signaling pathway -1.80 <0.001 0.004 
HTLV-I infection -1.79 <0.001 0.004 
Fc gamma R-mediated phagocytosis -1.79 <0.001 0.005 
Pancreatic cancer -1.78 <0.001 0.005 
Measles -1.77 <0.001 0.006 
Arginine and proline metabolism -1.77 <0.001 0.005 
Chemokine signaling pathway -1.76 <0.001 0.006 
Cell cycle -1.76 <0.001 0.006 
Bacterial invasion of epithelial cells -1.75 0.002 0.007 
Regulation of actin cytoskeleton -1.74 <0.001 0.007 
Glioma -1.74 <0.001 0.007 
Natural killer cell mediated cytotoxicity -1.74 <0.001 0.007 
Transcriptional misregulation in cancer -1.74 <0.001 0.007 
Fc epsilon RI signaling pathway -1.74 <0.001 0.007 
Estrogen signaling pathway -1.72 <0.001 0.008 
Protein digestion and absorption -1.72 <0.001 0.008 
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Biosynthesis of amino acids -1.69 <0.001 0.011 
Hepatitis C -1.68 <0.001 0.012 
Pathways in cancer -1.67 <0.001 0.013 
MAPK signaling pathway -1.67 <0.001 0.013 
Sphingolipid signaling pathway -1.65 <0.001 0.015 
Acute myeloid leukemia -1.64 0.011 0.017 
Mineral absorption -1.63 0.008 0.018 
Adipocytokine signaling pathway -1.63 0.002 0.018 
Galactose metabolism -1.63 0.011 0.019 
Bladder cancer -1.62 0.011 0.020 
Melanoma -1.61 0.007 0.021 
Viral myocarditis -1.61 0.002 0.021 
Herpes simplex infection -1.60 0.002 0.022 
Cell adhesion molecules (CAMs) -1.58 0.002 0.027 
Non-alcoholic fatty liver disease (NAFLD) -1.56 0.002 0.029 
Colorectal cancer -1.55 0.009 0.031 
NOD-like receptor signaling pathway -1.55 0.011 0.031 
DNA replication -1.55 0.026 0.031 
Inflammatory bowel disease (IBD) -1.55 0.018 0.031 
Prolactin signaling pathway -1.54 0.007 0.036 
TGF-beta signaling pathway -1.53 0.014 0.036 
Hypertrophic cardiomyopathy (HCM) -1.51 0.012 0.043 
One carbon pool by folate -1.50 0.042 0.046 
Choline metabolism in cancer -1.50 0.003 0.046 
Central carbon metabolism in cancer -1.50 0.020 0.047 
Platelet activation -1.50 0.003 0.048 
Dopaminergic synapse 1.51 0.005 0.082 
Parkinson's disease 1.53 0.002 0.079 
Neuroactive ligand-receptor interaction 1.55 <0.001 0.072 
Salivary secretion 1.56 0.002 0.070 
Cocaine addiction 1.73 0.004 0.015 
Calcium signaling pathway 1.77 <0.001 0.011 
Circadian entrainment 1.78 <0.001 0.010 
Axon guidance 1.83 <0.001 0.007 
GABAergic synapse 1.87 <0.001 0.005 
Retrograde endocannabinoid signaling 1.97 <0.001 0.001 
Morphine addiction 2.03 <0.001 0.001 
Glutamatergic synapse 2.08 <0.001 0.001 
Nicotine addiction 2.41 <0.001 <0.001 
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Table 10. Comparison of transcriptomes of normoxic brain tissue from Ephb2+/+ and Ephb2-/- mice. 
Mice were subjected to 60 min middle cerebral artery occlusion (MCAo) followed by 48 h of reperfu-
sion. DNA microarray and gene set enrichment analysis of the contralateral hemispheres showed 
differentially regulated pathways (obtained from KEGG database). N=3. Only pathways showing NES 
>1.5 or <-1.5, p<0.05 and FDR<0.1 were included. NES=normalized enrichment score, FDR=false 
discovery rate 
Pathway NES p value FDR  
Nicotine addiction 2.02 <0.001 0.004 
Long-term potentiation 1.87 <0.001 0.023 
Glutamatergic synapse 1.83 <0.001 0.023 
Retrograde endocannabinoid signaling 1.77 <0.001 0.042 
Long-term depression 1.69 0.008 0.075 
Osteoclast differentiation -1.50 0.004 0.088 
Hepatitis B -1.50 <0.001 0.089 
Central carbon metabolism in cancer -1.51 0.017 0.090 
Fatty acid elongation -1.51 0.044 0.090 
2-Oxocarboxylic acid metabolism -1.54 0.032 0.074 
Arginine and proline metabolism -1.54 0.016 0.073 
Tryptophan metabolism -1.55 0.024 0.072 
Chronic myeloid leukemia -1.55 0.008 0.074 
Adipocytokine signaling pathway -1.55 0.010 0.072 
Epstein-Barr virus infection -1.56 0.002 0.073 
Parkinson's disease -1.57 0.005 0.067 
Fatty acid degradation -1.58 0.009 0.065 
Non-alcoholic fatty liver disease (NAFLD) -1.60 <0.001 0.055 
Selenocompound metabolism -1.62 0.015 0.051 
Notch signaling pathway -1.63 0.011 0.044 
beta-Alanine metabolism -1.64 0.010 0.045 
Ribosome -1.64 0.004 0.046 
Fructose and mannose metabolism -1.65 0.008 0.043 
Other types of O-glycan biosynthesis -1.66 0.010 0.042 
Drug metabolism - cytochrome P450 -1.68 <0.001 0.036 
Purine metabolism -1.69 <0.001 0.035 
Valine, leucine and isoleucine degradation -1.69 0.002 0.036 
Pertussis -1.70 0.002 0.036 
Nitrogen metabolism -1.70 0.016 0.036 
Chemical carcinogenesis -1.72 <0.001 0.031 
Sphingolipid metabolism -1.73 0.002 0.028 
Other glycan degradation -1.74 0.006 0.031 
Small cell lung cancer -1.75 <0.001 0.029 
Biosynthesis of amino acids -1.81 0.002 0.014 
Metabolism of xenobiotics by cytochrome P450 -1.85 <0.001 0.010 
Glycosaminoglycan degradation -1.91 <0.001 0.005 
Lysosome -1.98 <0.001 0.002 
Pyrimidine metabolism -2.00 <0.001 0.003 
Complement and coagulation cascades -2.01 <0.001 0.002 
Staphylococcus aureus infection -2.13 <0.001 0.001 
RNA polymerase -2.14 0.002 0.001 
Glutathione metabolism -2.38 <0.001 <0.001 
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